,numCTs,unitProt,numVariantsGDA,HPOClass,type,evidenceIndexGDA,numDiseasesAssociatedToGene,geneNcbiID,numPMIDs,evidenceLevelGDA,geneEnsemblIDs,geneNcbiType,geneDSI,geneFullName,genePLI,diseaseUMLSCUI,disease,gene,numVariantsAssociatedToGene,numberPmidsWithChemsIncludedInEvidence,lastRef,numberChemsIncludedInEvidence,pathwayNames,geneDPI,pathwayIDs,numVariantsDisease,proteinClass,DOClass,diseaseClass,semanticType,numGenesDisease,firstRef,scoreGDA
,8,P32245,73,Growth abnormality (01507),disease,0.891803278688525,16,4160,96,,ENSG00000166603,protein-coding,0.51,melanocortin 4 receptor,0.000020768,C0028754,Obesity,MC4R,96,2,2018,2,"Developmental Biology,Signal Transduction",0.87,"R-HSA-1266738,R-HSA-162582",345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1957,1
,3,"P13945,A8KAG8",3,Growth abnormality (01507),disease,0.798283261802575,23,155,16,,ENSG00000188778,protein-coding,0.5,adrenoceptor beta 3,2.7754E-16,C0028754,Obesity,ADRB3,3,0,2004,0,Signal Transduction,0.83,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1995,1
,168,"P41159,A4D0Y8",0,Growth abnormality (01507),disease,0.888,59,3952,15,,ENSG00000174697,protein-coding,0.31,leptin,0.0070036,C0028754,Obesity,LEP,66,1,2019,1,"Developmental Biology,Signal Transduction,Metabolism of proteins",0.96,"R-HSA-1266738,R-HSA-162582,R-HSA-392499",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1997,1
,7,"Q4G138,P48357",2,Growth abnormality (01507),disease,0.863453815261044,67,3953,14,,ENSG00000116678,protein-coding,0.41,leptin receptor,0.000088607,C0028754,Obesity,LEPR,98,2,2023,2,Signal Transduction,0.96,R-HSA-162582,345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1986,1
,14,P01189,26,Growth abnormality (01507),disease,0.865079365079365,115,5443,9,,ENSG00000115138,protein-coding,0.32,proopiomelanocortin,3.3396E-10,C0028754,Obesity,POMC,40,0,2013,0,"Developmental Biology,Metabolism,Signal Transduction,Disease,Immune System,Metabolism of proteins,Gene expression (Transcription)",0.96,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-74160",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1998,1
,5,"A0A1B0GTC5,Q99770,Q9C0B1,B3KU60",9,Growth abnormality (01507),disease,0.901891252955083,32,79068,6,,ENSG00000140718,protein-coding,0.43,FTO alpha-ketoglutarate dependent dioxygenase,1.1171E-10,C0028754,Obesity,FTO,226,0,2010,0,DNA Repair,0.96,R-HSA-73894,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2007,1
,98,"Q5STB3,P01375",0,Growth abnormality (01507),disease,0.878581173260573,308,7124,4,,ENSG00000232810,protein-coding,0.23,tumor necrosis factor,0.85687,C0028754,Obesity,TNF,9,2,2018,1,"Developmental Biology,Signal Transduction,Immune System",0.96,"R-HSA-1266738,R-HSA-162582,R-HSA-168256",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1998,1
,543,"I3WAC9,P01308",0,Growth abnormality (01507),disease,0.869399428026692,95,3630,4,,ENSG00000254647,protein-coding,0.25,insulin,0.019763,C0028754,Obesity,INS,62,1,2018,1,"Developmental Biology,Metabolism,Signal Transduction,Metabolism of proteins,Vesicle-mediated transport,Gene expression (Transcription)",0.96,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-392499,R-HSA-5653656,R-HSA-74160",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1989,1
,95,Q9UBU3,3,Growth abnormality (01507),disease,0.882226980728051,25,51738,3,,ENSG00000157017,protein-coding,0.37,ghrelin and obestatin prepropeptide,0.00009528,C0028754,Obesity,GHRL,4,0,2005,0,"Signal Transduction,Metabolism of proteins",0.96,"R-HSA-162582,R-HSA-392499",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2001,1
,48,P10082,1,Growth abnormality (01507),disease,0.815533980582524,10,5697,3,,ENSG00000131096,protein-coding,0.5,peptide YY,0.000020343,C0028754,Obesity,PYY,64,0,2006,0,Signal Transduction,0.83,R-HSA-162582,345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2000,1
,3,"E9PFX5,D2KUA6,P37231,A0A494C1F9,E9PFV2",14,Growth abnormality (01507),disease,0.917127071823204,77,5468,3,,ENSG00000132170,protein-coding,0.33,peroxisome proliferator activated receptor gamma,0.21172,C0028754,Obesity,PPARG,103,0,2017,0,"Developmental Biology,Metabolism,Signal Transduction,Metabolism of proteins,Gene expression (Transcription)",0.96,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-392499,R-HSA-74160",345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1998,1
,114,"P05231,B4DVM1,Q75MH2,B5MC21,B4DNQ5",0,Growth abnormality (01507),disease,0.888888888888889,209,3569,2,,ENSG00000136244,protein-coding,0.23,interleukin 6,0.19935,C0028754,Obesity,IL6,5,0,2013,0,"Signal Transduction,Disease,Immune System,Metabolism of proteins,Gene expression (Transcription),Cellular responses to stimuli",0.96,"R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-74160,R-HSA-8953897",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,1
,107,"B2R773,A8K660,Q15848",0,Growth abnormality (01507),disease,0.90818128310771,43,9370,2,,ENSG00000181092,protein-coding,0.33,"adiponectin, C1Q and collagen domain containing",0.0000000035736,C0028754,Obesity,ADIPOQ,3,0,2003,0,"Developmental Biology,Metabolism",0.96,"R-HSA-1266738,R-HSA-1430728",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1999,1
,185,P02741,0,Growth abnormality (01507),disease,0.897694524495677,63,1401,1,,ENSG00000132693,protein-coding,0.25,C-reactive protein,0.0005414,C0028754,Obesity,CRP,1,0,2013,0,Immune System,1,R-HSA-168256,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,1
,6,P43490,0,Growth abnormality (01507),disease,0.876146788990826,8,10135,1,,ENSG00000105835,protein-coding,0.41,nicotinamide phosphoribosyltransferase,0.99993,C0028754,Obesity,NAMPT,0,0,2013,0,"Metabolism,Circadian Clock,Gene expression (Transcription)",0.91,"R-HSA-1430728,R-HSA-400253,R-HSA-74160",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,1
,5,P29120,0,Growth abnormality (01507),disease,0.837209302325581,5,5122,1,,ENSG00000175426,protein-coding,0.49,proprotein convertase subtilisin/kexin type 1,0.0000030514,C0028754,Obesity,PCSK1,99,0,2008,0,Metabolism of proteins,0.83,R-HSA-392499,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2008,1
,21,P13500,0,Growth abnormality (01507),disease,0.883720930232558,104,6347,1,,ENSG00000108691,protein-coding,0.31,C-C motif chemokine ligand 2,0.098507,C0028754,Obesity,CCL2,2,0,2018,0,"Signal Transduction,Immune System,Cellular responses to stimuli",0.96,"R-HSA-162582,R-HSA-168256,R-HSA-8953897",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,1
,2,"P55916,A0A0S2Z4G5",7,Growth abnormality (01507),disease,0.769230769230769,11,7352,1,,ENSG00000175564,protein-coding,0.58,uncoupling protein 3,0.000000078551,C0028754,Obesity,UCP3,10,0,1998,0,Metabolism,0.87,R-HSA-1430728,345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1998,1
,3,"Q96EB6,E9PC49,B0QZ35,A8K128",0,Growth abnormality (01507),disease,0.980952380952381,57,23411,1,,ENSG00000096717,protein-coding,0.37,sirtuin 1,0.89742,C0028754,Obesity,SIRT1,1,0,2014,0,"Developmental Biology,Circadian Clock,Gene expression (Transcription),Cellular responses to stimuli",0.96,"R-HSA-1266738,R-HSA-400253,R-HSA-74160,R-HSA-8953897",345,Epigenetic regulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2014,1
,4,P81133,1,Growth abnormality (01507),disease,0.764705882352941,9,6492,0,,ENSG00000112246,protein-coding,0.55,SIM bHLH transcription factor 1,1,C0028754,Obesity,SIM1,63,0,,0,,0.7,,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,1
,2,"C6SUN5,O00253",1,Growth abnormality (01507),disease,0.761904761904762,4,181,0,,ENSG00000159723,protein-coding,0.48,agouti related neuropeptide,0.018129,C0028754,Obesity,AGRP,2,0,,0,Gene expression (Transcription),0.96,R-HSA-74160,345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,1
,27,P09681,0,Growth abnormality (01507),disease,0.935323383084577,3,2695,0,,ENSG00000159224,protein-coding,0.48,gastric inhibitory polypeptide,0.0001024,C0028754,Obesity,GIP,11,0,,0,"Signal Transduction,Metabolism of proteins",0.87,"R-HSA-162582,R-HSA-392499",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,1
,13,Q9HD89,0,Growth abnormality (01507),disease,0.840182648401826,12,56729,0,,ENSG00000104918,protein-coding,0.4,resistin,0.0043156,C0028754,Obesity,RETN,1,0,,0,"Immune System,Gene expression (Transcription)",0.96,"R-HSA-168256,R-HSA-74160",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,1
,13,"P23560,A0A0E3SU01",4,Growth abnormality (01507),disease,0.914893617021277,54,627,0,,ENSG00000176697,protein-coding,0.32,brain derived neurotrophic factor,0.99974,C0028754,Obesity,BDNF,32,0,,0,"Signal Transduction,Disease,Gene expression (Transcription)",0.96,"R-HSA-162582,R-HSA-1643685,R-HSA-74160",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,1
,11,"Q9NSA1,A0A7U3L5M7",0,Growth abnormality (01507),disease,0.907692307692308,13,26291,2,,ENSG00000105550,protein-coding,0.43,fibroblast growth factor 21,0.000015619,C0028754,Obesity,FGF21,1,0,2016,0,Transport of small molecules,0.96,R-HSA-382551,345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2014,0.95
,0,"P28845,X5D2L1",0,Growth abnormality (01507),disease,0.938775510204082,16,3290,2,,ENSG00000117594,protein-coding,0.49,hydroxysteroid 11-beta dehydrogenase 1,0.0022053,C0028754,Obesity,HSD11B1,5,0,2011,0,"Metabolism,Drug ADME",0.96,"R-HSA-1430728,R-HSA-9748784",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2007,0.95
,2,"F1D8S4,Q07869",0,Growth abnormality (01507),disease,0.935483870967742,41,5465,2,,ENSG00000186951,protein-coding,0.39,peroxisome proliferator activated receptor alpha,0.0034658,C0028754,Obesity,PPARA,5,0,2019,0,"Developmental Biology,Metabolism,Organelle biogenesis and maintenance,Metabolism of proteins,Circadian Clock,Gene expression (Transcription),Cellular responses to stimuli",0.91,"R-HSA-1266738,R-HSA-1430728,R-HSA-1852241,R-HSA-392499,R-HSA-400253,R-HSA-74160,R-HSA-8953897",345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2000,0.95
,1,"B4DSN5,A8K3M3,P18031",0,Growth abnormality (01507),disease,0.961111111111111,17,5770,2,,ENSG00000196396,protein-coding,0.47,protein tyrosine phosphatase non-receptor type 1,1,C0028754,Obesity,PTPN1,4,1,2010,1,"Hemostasis,Signal Transduction,Immune System,Gene expression (Transcription)",0.91,"R-HSA-109582,R-HSA-162582,R-HSA-168256,R-HSA-74160",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2000,0.95
,6,"Q4KMT7,P25874",0,Growth abnormality (01507),disease,0.837349397590361,6,7350,1,,ENSG00000109424,protein-coding,0.53,uncoupling protein 1,9.1495E-10,C0028754,Obesity,UCP1,0,0,2004,0,"Developmental Biology,Metabolism",0.83,"R-HSA-1266738,R-HSA-1430728",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2004,0.95
,1,O60240,0,Growth abnormality (01507),disease,0.905660377358491,7,5346,1,,ENSG00000166819,protein-coding,0.54,perilipin 1,3.3689E-12,C0028754,Obesity,PLIN1,14,0,2004,0,"Developmental Biology,Metabolism,Signal Transduction",0.74,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2004,0.95
,0,P55851,0,Growth abnormality (01507),disease,0.826666666666667,20,7351,1,,ENSG00000175567,protein-coding,0.47,uncoupling protein 2,0.000000011875,C0028754,Obesity,UCP2,3,0,2001,0,Metabolism,0.91,R-HSA-1430728,345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2001,0.95
,0,"P21554,S5TLS4,V5KA96",0,Growth abnormality (01507),disease,0.901960784313726,47,1268,1,,ENSG00000118432,protein-coding,0.43,cannabinoid receptor 1,0.31479,C0028754,Obesity,CNR1,0,1,2008,1,Signal Transduction,0.96,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2008,0.95
,92,P01275,0,Growth abnormality (01507),disease,0.91437802907916,32,2641,1,,ENSG00000115263,protein-coding,0.35,glucagon,0.13736,C0028754,Obesity,GCG,1,0,2010,0,"Metabolism,Signal Transduction,Metabolism of proteins",0.96,"R-HSA-1430728,R-HSA-162582,R-HSA-392499",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.95
,11,"B1A4G6,P01241,B1A4G7",0,Growth abnormality (01507),disease,0.857723577235772,47,2688,1,,ENSG00000259384,protein-coding,0.31,growth hormone 1,0.012644,C0028754,Obesity,GH1,63,1,1996,1,"Immune System,Metabolism of proteins",0.96,"R-HSA-168256,R-HSA-392499",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1996,0.95
,16,P05121,0,Growth abnormality (01507),disease,0.897777777777778,65,5054,1,,ENSG00000106366,protein-coding,0.34,serpin family E member 1,0.03418,C0028754,Obesity,SERPINE1,56,1,2013,1,"Hemostasis,Extracellular matrix organization,Signal Transduction,Circadian Clock,Gene expression (Transcription)",0.96,"R-HSA-109582,R-HSA-1474244,R-HSA-162582,R-HSA-400253,R-HSA-74160",345,Enzyme modulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.95
,2,"P18065,C9JMY1",0,Growth abnormality (01507),disease,0.96875,7,3485,1,,ENSG00000115457,protein-coding,0.43,insulin like growth factor binding protein 2,0.0037854,C0028754,Obesity,IGFBP2,0,0,2012,0,Metabolism of proteins,0.83,R-HSA-392499,345,Enzyme modulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2012,0.95
,4,"A0A8I5KR47,Q5VWE5,Q548C2,Q16620",1,Growth abnormality (01507),disease,1,42,4915,1,,ENSG00000148053,protein-coding,0.45,neurotrophic receptor tyrosine kinase 2,1,C0028754,Obesity,NTRK2,27,0,2004,0,"Signal Transduction,Disease",0.96,"R-HSA-162582,R-HSA-1643685",345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2004,0.95
,1,"Q8N5P9,O60543,B3KVA2",0,Growth abnormality (01507),disease,1,4,1149,1,,ENSG00000176194,protein-coding,0.66,cell death inducing DFFA like effector a,0.0082513,C0028754,Obesity,CIDEA,0,0,2010,0,"Developmental Biology,Metabolism",0.57,"R-HSA-1266738,R-HSA-1430728",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.95
,0,"P02649,A0A0S2Z3D5",0,Growth abnormality (01507),disease,0.870229007633588,100,348,1,,ENSG00000130203,protein-coding,0.33,apolipoprotein E,0.00025529,C0028754,Obesity,APOE,33,0,2010,0,"Metabolism,Signal Transduction,Transport of small molecules,Metabolism of proteins,Vesicle-mediated transport,Gene expression (Transcription),Sensory Perception",0.96,"R-HSA-1430728,R-HSA-162582,R-HSA-382551,R-HSA-392499,R-HSA-5653656,R-HSA-74160,R-HSA-9709957",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.95
,1,"A0A140VJG8,P21964",0,Growth abnormality (01507),disease,0.833333333333333,80,1312,0,,ENSG00000093010,protein-coding,0.38,catechol-O-methyltransferase,0.00049511,C0028754,Obesity,COMT,21,0,,0,"Neuronal System,Metabolism,Disease",0.96,"R-HSA-112316,R-HSA-1430728,R-HSA-1643685",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.95
,0,P22413,20,Growth abnormality (01507),disease,0.8,16,5167,14,,ENSG00000197594,protein-coding,0.43,ectonucleotide pyrophosphatase/phosphodiesterase 1,0.000016968,C0028754,Obesity,ENPP1,187,0,2006,0,Metabolism,0.91,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1998,0.95
,0,Q16568,1,Growth abnormality (01507),disease,0.88,11,9607,2,,ENSG00000164326,protein-coding,0.53,CART prepropeptide,0.12691,C0028754,Obesity,CARTPT,1,0,2004,0,,0.78,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2001,0.95
,0,"Q5FWY2,Q14455,B0AZR9,Q5JWF2,A0A0S2Z3H8,O95467,Q5JWD1,P63092,P84996,A0A590UJF0,A0A7I2V5R6,A0A0S2Z3S5",1,Growth abnormality (01507),disease,0.870967741935484,65,2778,1,,ENSG00000087460,protein-coding,0.38,GNAS complex locus,0.99999,C0028754,Obesity,GNAS,130,0,2006,0,"Hemostasis,Metabolism,Signal Transduction,Disease,Transport of small molecules",0.96,"R-HSA-109582,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-382551",345,Enzyme modulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2006,0.95
,0,Q15466,4,Growth abnormality (01507),disease,0.875,12,8431,1,,ENSG00000131910,protein-coding,0.47,nuclear receptor subfamily 0 group B member 2,0.000004235,C0028754,Obesity,NR0B2,7,0,2008,0,Gene expression (Transcription),0.87,R-HSA-74160,345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2008,0.95
,6,P00734,0,Growth abnormality (01507),disease,0.961538461538462,65,2147,1,,ENSG00000180210,protein-coding,0.33,"coagulation factor II, thrombin",,C0028754,Obesity,F2,71,0,2012,0,"Hemostasis,Signal Transduction,Disease,Immune System,Metabolism of proteins",0.96,"R-HSA-109582,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-392499",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2012,0.9
,1,"A0A0A0MSC1,B7ZLX9,O60266",2,Growth abnormality (01507),disease,0.956521739130435,7,109,1,,ENSG00000138031,protein-coding,0.61,adenylate cyclase 3,3.6985E-11,C0028754,Obesity,ADCY3,37,0,2018,0,"Neuronal System,Metabolism,Signal Transduction,Disease,Transport of small molecules,Sensory Perception",0.7,"R-HSA-112316,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-382551,R-HSA-9709957",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.9
,0,"A0A125SXW3,H0Y4W6,P03372,Q9UBT1,A8KAF4,G4XH65",0,Growth abnormality (01507),disease,0.877862595419847,74,2099,1,,ENSG00000091831,protein-coding,0.3,estrogen receptor 1,0.99791,C0028754,Obesity,ESR1,247,0,2010,0,"Signal Transduction,Disease,Metabolism of proteins,Gene expression (Transcription)",0.96,"R-HSA-162582,R-HSA-1643685,R-HSA-392499,R-HSA-74160",345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.9
,0,"P31749,B0LPE5,B3KVH4",0,Growth abnormality (01507),disease,0.887096774193548,85,207,1,,ENSG00000142208,protein-coding,0.28,AKT serine/threonine kinase 1,0.99533,C0028754,Obesity,AKT1,159,0,2013,0,"Hemostasis,Developmental Biology,Metabolism,Signal Transduction,Cell Cycle,Disease,Immune System,Programmed Cell Death,Vesicle-mediated transport,Gene expression (Transcription),Metabolism of RNA,Cellular responses to stimuli",0.96,"R-HSA-109582,R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-1640170,R-HSA-1643685,R-HSA-168256,R-HSA-5357801,R-HSA-5653656,R-HSA-74160,R-HSA-8953854,R-HSA-8953897",345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.9
,1,P35354,0,Growth abnormality (01507),disease,0.952380952380952,143,5743,1,,ENSG00000073756,protein-coding,0.32,prostaglandin-endoperoxide synthase 2,1,C0028754,Obesity,PTGS2,1,0,2011,0,"Metabolism,Immune System",0.96,"R-HSA-1430728,R-HSA-168256",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.9
,6,"P05362,A0A384MEK5",0,Growth abnormality (01507),disease,0.851851851851852,61,3383,1,,ENSG00000090339,protein-coding,0.33,intercellular adhesion molecule 1,0.000001834,C0028754,Obesity,ICAM1,7,0,2002,0,"Extracellular matrix organization,Immune System",0.96,"R-HSA-1474244,R-HSA-168256",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2002,0.9
,6,"A0PJA6,Q06AH7,P02787",0,Growth abnormality (01507),disease,0.88,38,7018,1,,ENSG00000091513,protein-coding,0.37,transferrin,,C0028754,Obesity,TF,68,0,2011,0,"Hemostasis,Transport of small molecules,Metabolism of proteins,Vesicle-mediated transport",0.96,"R-HSA-109582,R-HSA-382551,R-HSA-392499,R-HSA-5653656",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.9
,0,"A0A1B1RVA9,P06858",0,Growth abnormality (01507),disease,0.878048780487805,39,4023,1,,ENSG00000175445,protein-coding,0.43,lipoprotein lipase,3.0524E-12,C0028754,Obesity,LPL,211,0,2008,0,"Developmental Biology,Metabolism,Transport of small molecules,Sensory Perception",0.87,"R-HSA-1266738,R-HSA-1430728,R-HSA-382551,R-HSA-9709957",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2008,0.9
,0,P35568,0,Growth abnormality (01507),disease,0.833333333333333,20,3667,1,,ENSG00000169047,protein-coding,0.45,insulin receptor substrate 1,0.00013176,C0028754,Obesity,IRS1,9,0,2013,0,"Signal Transduction,Disease,Immune System",0.91,"R-HSA-162582,R-HSA-1643685,R-HSA-168256",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.9
,3,P14780,0,Growth abnormality (01507),disease,0.810810810810811,107,4318,1,,ENSG00000100985,protein-coding,0.29,matrix metallopeptidase 9,3.7082E-25,C0028754,Obesity,MMP9,38,0,2011,0,"Developmental Biology,Extracellular matrix organization,Signal Transduction,Immune System",0.96,"R-HSA-1266738,R-HSA-1474244,R-HSA-162582,R-HSA-168256",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.9
,4,"Q9NRF2,B3KNV5,B4DLN5",1,Growth abnormality (01507),disease,0.838709677419355,6,25970,1,,ENSG00000178188,protein-coding,0.49,SH2B adaptor protein 1,0.99999,C0028754,Obesity,SH2B1,45,0,2009,0,"Hemostasis,Signal Transduction,Immune System",0.91,"R-HSA-109582,R-HSA-162582,R-HSA-168256",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.9
,1,"Q86YN6,B7ZM40",0,Growth abnormality (01507),disease,0.769230769230769,5,133522,1,,ENSG00000155846,protein-coding,0.57,PPARG coactivator 1 beta,0.99973,C0028754,Obesity,PPARGC1B,16,0,2019,0,"Developmental Biology,Metabolism,Organelle biogenesis and maintenance,Gene expression (Transcription)",0.78,"R-HSA-1266738,R-HSA-1430728,R-HSA-1852241,R-HSA-74160",345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2019,0.9
,3,"P01019,B2R5S1,B0ZBE2",0,Growth abnormality (01507),disease,0.870967741935484,108,183,0,,ENSG00000135744,protein-coding,0.34,angiotensinogen,0.000000016654,C0028754,Obesity,AGT,74,0,,0,"Metabolism,Signal Transduction,Metabolism of proteins",0.96,"R-HSA-1430728,R-HSA-162582,R-HSA-392499",345,Enzyme modulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.9
,4,"G8XRH4,L0E130,B8K2Q5,G8XRH5,P35372",0,Growth abnormality (01507),disease,1,43,4988,0,,ENSG00000112038,protein-coding,0.45,opioid receptor mu 1,0.00000041408,C0028754,Obesity,OPRM1,16,0,,0,"Signal Transduction,Immune System,Gene expression (Transcription)",0.96,"R-HSA-162582,R-HSA-168256,R-HSA-74160",345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.9
,2,P16860,0,Growth abnormality (01507),disease,0.837837837837838,41,4879,0,,ENSG00000120937,protein-coding,0.39,natriuretic peptide B,0.000018925,C0028754,Obesity,NPPB,1,0,,0,,0.91,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.9
,4,P41968,0,Growth abnormality (01507),disease,0.789473684210526,2,4159,0,,ENSG00000124089,protein-coding,0.63,melanocortin 3 receptor,0.00058423,C0028754,Obesity,MC3R,3,0,,0,"Developmental Biology,Signal Transduction",0.74,"R-HSA-1266738,R-HSA-162582",345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.9
,4,"P05305,Q6FH53",0,Growth abnormality (01507),disease,0.877551020408163,74,1906,0,,ENSG00000078401,protein-coding,0.35,endothelin 1,0.0044888,C0028754,Obesity,EDN1,9,0,,0,"Developmental Biology,Signal Transduction",0.96,"R-HSA-1266738,R-HSA-162582",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.9
,2,"A0N0L5,A0A087WTB5,P08887",0,Growth abnormality (01507),disease,0.9,26,3570,0,,ENSG00000160712,protein-coding,0.42,interleukin 6 receptor,0.000000067914,C0028754,Obesity,IL6R,33,0,,0,"Developmental Biology,Signal Transduction,Disease,Immune System",0.87,"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-168256",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.9
,2,"E5KQF6,E5KQF5,P04150,F1D8N4",0,Growth abnormality (01507),disease,0.830769230769231,41,2908,0,,ENSG00000113580,protein-coding,0.37,nuclear receptor subfamily 3 group C member 1,1,C0028754,Obesity,NR3C1,116,0,,0,"Signal Transduction,Disease,Metabolism of proteins,Circadian Clock,Gene expression (Transcription),Cellular responses to stimuli",0.96,"R-HSA-162582,R-HSA-1643685,R-HSA-392499,R-HSA-400253,R-HSA-74160,R-HSA-8953897",345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.9
,1,P14416,0,Growth abnormality (01507),disease,0.894736842105263,55,1813,0,,ENSG00000149295,protein-coding,0.4,dopamine receptor D2,0.99986,C0028754,Obesity,DRD2,30,0,,0,Signal Transduction,0.96,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.9
,1,"P06850,A0A0S2Z478",0,Growth abnormality (01507),disease,0.933333333333333,43,1392,0,,ENSG00000147571,protein-coding,0.42,corticotropin releasing hormone,0.0059146,C0028754,Obesity,CRH,1,0,,0,"Signal Transduction,Gene expression (Transcription)",0.91,"R-HSA-162582,R-HSA-74160",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.9
,0,"Q9UG55,O00519",0,Growth abnormality (01507),disease,0.878787878787879,9,2166,2,,ENSG00000117480,protein-coding,0.5,fatty acid amide hydrolase,9.2899E-21,C0028754,Obesity,FAAH,2,0,2011,0,Metabolism,0.91,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.85
,0,"P28335,K9J958",0,Growth abnormality (01507),disease,0.910714285714286,19,3358,2,,ENSG00000147246,protein-coding,0.51,5-hydroxytryptamine receptor 2C,,C0028754,Obesity,HTR2C,2,1,2009,1,Signal Transduction,0.83,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2007,0.85
,0,"P16870,A0A384N679",0,Growth abnormality (01507),disease,0.774193548387097,7,1363,2,,ENSG00000109472,protein-coding,0.52,carboxypeptidase E,0.83148,C0028754,Obesity,CPE,13,1,2013,1,Metabolism of proteins,0.83,R-HSA-392499,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2004,0.85
,0,P28223,0,Growth abnormality (01507),disease,0.714285714285714,43,3356,1,,ENSG00000102468,protein-coding,0.44,5-hydroxytryptamine receptor 2A,0.35656,C0028754,Obesity,HTR2A,3,0,2006,0,Signal Transduction,0.91,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2006,0.85
,0,"P07550,X5DQM5",0,Growth abnormality (01507),disease,0.84,49,154,1,,ENSG00000169252,protein-coding,0.42,adrenoceptor beta 2,0.0010085,C0028754,Obesity,ADRB2,3,0,2005,0,"Signal Transduction,Metabolism of proteins,Vesicle-mediated transport",0.96,"R-HSA-162582,R-HSA-392499,R-HSA-5653656",345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2005,0.85
,0,O43612,0,Growth abnormality (01507),disease,0.976190476190476,17,3060,1,,ENSG00000161610,protein-coding,0.45,hypocretin neuropeptide precursor,0.0030594,C0028754,Obesity,HCRT,1,0,2016,0,Signal Transduction,0.96,R-HSA-162582,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.85
,0,Q9BXC9,0,Growth abnormality (01507),disease,0.923076923076923,13,583,0,,ENSG00000125124,protein-coding,0.53,Bardet-Biedl syndrome 2,5.9888E-15,C0028754,Obesity,BBS2,354,0,,0,Organelle biogenesis and maintenance,0.87,R-HSA-1852241,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.85
,0,P48546,2,Growth abnormality (01507),disease,0.971428571428571,5,2696,0,,ENSG00000010310,protein-coding,0.6,gastric inhibitory polypeptide receptor,7.1956E-26,C0028754,Obesity,GIPR,17,0,,0,Signal Transduction,0.7,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.85
,0,"B7Z3W9,Q9NPJ1",0,Growth abnormality (01507),disease,0.866666666666667,13,8195,0,,ENSG00000125863,protein-coding,0.51,MKKS centrosomal shuttling protein,9.7525E-11,C0028754,Obesity,MKKS,208,0,,0,Organelle biogenesis and maintenance,0.91,R-HSA-1852241,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.85
,1,"Q03181,F1D8S7",0,Growth abnormality (01507),disease,0.875,17,5467,2,,ENSG00000112033,protein-coding,0.45,peroxisome proliferator activated receptor delta,0.99998,C0028754,Obesity,PPARD,18,2,2010,2,"Metabolism,Signal Transduction,Gene expression (Transcription)",0.91,"R-HSA-1430728,R-HSA-162582,R-HSA-74160",345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2005,0.85
,9,"P18428,Q8TCF0",0,Growth abnormality (01507),disease,0.909090909090909,10,3929,1,,ENSG00000129988,protein-coding,0.46,lipopolysaccharide binding protein,6.7841E-14,C0028754,Obesity,LBP,0,0,2013,0,Immune System,0.96,R-HSA-168256,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.85
,2,P49327,0,Growth abnormality (01507),disease,0.907407407407407,29,2194,1,,ENSG00000169710,protein-coding,0.43,fatty acid synthase,1,C0028754,Obesity,FASN,666,0,2011,0,"Metabolism,Signal Transduction",0.96,"R-HSA-1430728,R-HSA-162582",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.85
,1,Q86VB7,0,Growth abnormality (01507),disease,0.857142857142857,12,9332,1,,ENSG00000177575,protein-coding,0.42,CD163 molecule,0.00050078,C0028754,Obesity,CD163,6,0,2018,0,"Disease,Vesicle-mediated transport",0.91,"R-HSA-1643685,R-HSA-5653656",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.85
,1,Q96B42,0,Growth abnormality (01507),disease,0.912280701754386,2,129787,1,,ENSG00000151353,protein-coding,0.74,transmembrane protein 18,0.00013512,C0028754,Obesity,TMEM18,5,0,2009,0,,0.39,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.85
,1,,0,Growth abnormality (01507),disease,1,17,406991,1,,ENSG00000284190,ncRNA,0.37,microRNA 21,,C0028754,Obesity,MIR21,1,0,2013,0,,0.96,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.85
,1,O00767,0,Growth abnormality (01507),disease,0.973684210526316,22,6319,1,,ENSG00000099194,protein-coding,0.48,stearoyl-CoA desaturase,1,C0028754,Obesity,SCD,1,0,2011,0,"Metabolism,Signal Transduction",0.87,"R-HSA-1430728,R-HSA-162582",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.85
,1,P20333,0,Growth abnormality (01507),disease,0.777777777777778,31,7133,1,,ENSG00000028137,protein-coding,0.4,TNF receptor superfamily member 1B,0.10032,C0028754,Obesity,TNFRSF1B,1,0,2002,0,Immune System,0.91,R-HSA-168256,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2002,0.85
,2,Q9BY76,0,Growth abnormality (01507),disease,1,16,51129,1,,ENSG00000167772,protein-coding,0.48,angiopoietin like 4,3.5878E-16,C0028754,Obesity,ANGPTL4,7,0,2017,0,"Developmental Biology,Metabolism,Cell-Cell communication,Transport of small molecules",0.91,"R-HSA-1266738,R-HSA-1430728,R-HSA-1500931,R-HSA-382551",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2017,0.85
,1,"P07203,A0A2R8Y6B6,Q7L4Q3",0,Growth abnormality (01507),disease,0.666666666666667,76,2876,1,,ENSG00000233276,protein-coding,0.42,glutathione peroxidase 1,0.0019011,C0028754,Obesity,GPX1,1,0,2004,0,"Metabolism,Cellular responses to stimuli",0.91,"R-HSA-1430728,R-HSA-8953897",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2004,0.85
,7,"V9HWC9,P00441",0,Growth abnormality (01507),disease,0.883720930232558,90,6647,1,,ENSG00000142168,protein-coding,0.33,superoxide dismutase 1,0.011954,C0028754,Obesity,SOD1,133,0,2013,0,"Hemostasis,Immune System,Cellular responses to stimuli",1,"R-HSA-109582,R-HSA-168256,R-HSA-8953897",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.85
,4,P12104,0,Growth abnormality (01507),disease,0.825,9,2169,0,,ENSG00000145384,protein-coding,0.49,fatty acid binding protein 2,0.16064,C0028754,Obesity,FABP2,1,0,,0,Metabolism,0.91,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.85
,0,P42127,0,Growth abnormality (01507),disease,0.92,22,434,5,,ENSG00000101440,protein-coding,0.58,agouti signaling protein,0.000017622,C0028754,Obesity,ASIP,4,0,2020,0,,0.83,,345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,1992,0.8
,0,P35869,0,Growth abnormality (01507),disease,0.774193548387097,74,196,3,,ENSG00000106546,protein-coding,0.38,aryl hydrocarbon receptor,0.0077533,C0028754,Obesity,AHR,1,0,2019,0,Metabolism,0.96,R-HSA-1430728,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.8
,0,P22352,0,Growth abnormality (01507),disease,0.933333333333333,34,2878,2,,ENSG00000211445,protein-coding,0.45,glutathione peroxidase 3,0.000000010819,C0028754,Obesity,GPX3,1,1,2009,1,Cellular responses to stimuli,0.91,R-HSA-8953897,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2001,0.8
,0,Q7Z5J4,0,Growth abnormality (01507),disease,1,21,10743,2,,ENSG00000108557,protein-coding,0.5,retinoic acid induced 1,1,C0028754,Obesity,RAI1,79,0,2009,0,"Circadian Clock,Cellular responses to stimuli",0.87,"R-HSA-400253,R-HSA-8953897",345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2004,0.8
,0,P05181,0,Growth abnormality (01507),disease,0.892857142857143,48,1571,1,,ENSG00000130649,protein-coding,0.44,cytochrome P450 family 2 subfamily E member 1,0.00000012359,C0028754,Obesity,CYP2E1,4,0,2013,0,"Metabolism,Drug ADME",0.96,"R-HSA-1430728,R-HSA-9748784",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.8
,0,Q9NTG7,0,Growth abnormality (01507),disease,0.970588235294118,5,23410,1,,ENSG00000142082,protein-coding,0.44,sirtuin 3,0.00000011263,C0028754,Obesity,SIRT3,10,0,2013,0,"Metabolism,Organelle biogenesis and maintenance,Gene expression (Transcription)",0.91,"R-HSA-1430728,R-HSA-1852241,R-HSA-74160",345,Epigenetic regulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.8
,0,P20382,0,Growth abnormality (01507),disease,0.933333333333333,5,5367,1,,ENSG00000183395,protein-coding,0.57,pro-melanin concentrating hormone,0.17328,C0028754,Obesity,PMCH,0,0,2002,0,Signal Transduction,0.83,R-HSA-162582,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2002,0.8
,0,"O43524,A0A856PRE8",0,Growth abnormality (01507),disease,1,8,2309,1,,ENSG00000118689,protein-coding,0.42,forkhead box O3,0.99997,C0028754,Obesity,FOXO3,23,0,2013,0,"Developmental Biology,Signal Transduction,Disease,Immune System,Gene expression (Transcription)",0.91,"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-74160",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.8
,0,Q7Z3B1,1,Growth abnormality (01507),disease,0.880952380952381,1,257194,1,,ENSG00000172260,protein-coding,0.61,neuronal growth regulator 1,0.99553,C0028754,Obesity,NEGR1,67,0,2009,0,Metabolism of proteins,0.78,R-HSA-392499,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.8
,0,"P36956,B3KR77",0,Growth abnormality (01507),disease,0.907692307692308,20,6720,1,,ENSG00000072310,protein-coding,0.45,sterol regulatory element binding transcription factor 1,0.000003898,C0028754,Obesity,SREBF1,12,1,2000,1,"Developmental Biology,Metabolism,Signal Transduction,Circadian Clock,Gene expression (Transcription)",0.91,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-400253,R-HSA-74160",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2000,0.8
,0,Q9HC96,0,Growth abnormality (01507),disease,0.833333333333333,12,11132,0,,ENSG00000142330,protein-coding,0.58,calpain 10,1.201E-22,C0028754,Obesity,CAPN10,3,0,,0,Extracellular matrix organization,0.7,R-HSA-1474244,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,P26441,0,Growth abnormality (01507),disease,0.875,12,1270,0,,ENSG00000242689,protein-coding,0.52,ciliary neurotrophic factor,0.0000049324,C0028754,Obesity,CNTF,0,0,,0,Immune System,0.91,R-HSA-168256,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,"P14174,I4AY87",0,Growth abnormality (01507),disease,0.941176470588235,29,4282,0,,ENSG00000240972,protein-coding,0.4,macrophage migration inhibitory factor,0.000000022471,C0028754,Obesity,MIF,0,0,,0,"Hemostasis,Immune System",0.96,"R-HSA-109582,R-HSA-168256",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,P49146,0,Growth abnormality (01507),disease,0.933333333333333,9,4887,0,,ENSG00000185149,protein-coding,0.63,neuropeptide Y receptor Y2,0.000052469,C0028754,Obesity,NPY2R,1,0,,0,Signal Transduction,0.83,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,Q99958,0,Growth abnormality (01507),disease,0.909090909090909,14,2303,0,,ENSG00000176692,protein-coding,0.48,forkhead box C2,0.00066313,C0028754,Obesity,FOXC2,30,0,,0,Developmental Biology,0.87,R-HSA-1266738,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,"Q9NUA2,P10275,A0A087WUX9,G4VV16,F1D8N5",0,Growth abnormality (01507),disease,1,42,367,0,,ENSG00000169083,protein-coding,0.33,androgen receptor,,C0028754,Obesity,AR,242,0,,0,"Signal Transduction,Metabolism of proteins,Gene expression (Transcription),Cellular responses to stimuli",0.96,"R-HSA-162582,R-HSA-392499,R-HSA-74160,R-HSA-8953897",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,"P24666,Q59EH3,A0A140VK37",0,Growth abnormality (01507),disease,0.772727272727273,14,52,0,,ENSG00000143727,protein-coding,0.48,acid phosphatase 1,0.0000001469,C0028754,Obesity,ACP1,3,0,,0,,0.91,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,"P55157,B7Z7X3",0,Growth abnormality (01507),disease,1,11,4547,0,,ENSG00000138823,protein-coding,0.47,microsomal triglyceride transfer protein,0.00000064626,C0028754,Obesity,MTTP,166,0,,0,Transport of small molecules,0.83,R-HSA-382551,345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,"P36955,A0A140VKF3",0,Growth abnormality (01507),disease,0.925925925925926,33,5176,0,,ENSG00000132386,protein-coding,0.42,serpin family F member 1,0.000000018885,C0028754,Obesity,SERPINF1,78,0,,0,,0.91,,345,Enzyme modulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,"F1D8N1,Q13133,B5MBY7,B4DXU5",0,Growth abnormality (01507),disease,0.882352941176471,9,10062,0,,ENSG00000025434,protein-coding,0.48,nuclear receptor subfamily 1 group H member 3,0.75938,C0028754,Obesity,NR1H3,12,0,,0,"Metabolism,Signal Transduction,Transport of small molecules,Metabolism of proteins,Gene expression (Transcription)",0.83,"R-HSA-1430728,R-HSA-162582,R-HSA-382551,R-HSA-392499,R-HSA-74160",345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,Q92847,0,Growth abnormality (01507),disease,0.843137254901961,5,2693,0,,ENSG00000121853,protein-coding,0.5,growth hormone secretagogue receptor,0.00009143,C0028754,Obesity,GHSR,52,0,,0,Signal Transduction,0.87,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,O15528,0,Growth abnormality (01507),disease,0.733333333333333,12,1594,0,,ENSG00000111012,protein-coding,0.43,cytochrome P450 family 27 subfamily B member 1,9.067E-14,C0028754,Obesity,CYP27B1,71,0,,0,"Metabolism,Disease",0.91,"R-HSA-1430728,R-HSA-1643685",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,P02654,0,Growth abnormality (01507),disease,0.9,4,341,0,,ENSG00000130208,protein-coding,0.52,apolipoprotein C1,0.11905,C0028754,Obesity,APOC1,21,0,,0,"Signal Transduction,Transport of small molecules",0.78,"R-HSA-162582,R-HSA-382551",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,"O95477,B2RUU2,B7XCW9",0,Growth abnormality (01507),disease,0.862068965517241,31,19,0,,ENSG00000165029,protein-coding,0.44,ATP binding cassette subfamily A member 1,2.0444E-12,C0028754,Obesity,ABCA1,281,0,,0,"Metabolism,Signal Transduction,Disease,Transport of small molecules",0.91,"R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-382551",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,P06401,0,Growth abnormality (01507),disease,0.6875,14,5241,0,,ENSG00000082175,protein-coding,0.36,progesterone receptor,0.71712,C0028754,Obesity,PGR,4,0,,0,"Signal Transduction,Metabolism of proteins,Gene expression (Transcription),Cellular responses to stimuli",0.91,"R-HSA-162582,R-HSA-392499,R-HSA-74160,R-HSA-8953897",345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,4,"Q7Z3E0,B7Z2I6,A0A8V8TM46,A8K6Q8,G3V0E5,P02786",0,Growth abnormality (01507),disease,0.933333333333333,29,7037,2,,ENSG00000072274,protein-coding,0.39,transferrin receptor,0.98338,C0028754,Obesity,TFRC,17,0,2011,0,"Developmental Biology,Signal Transduction,Transport of small molecules,Vesicle-mediated transport",0.96,"R-HSA-1266738,R-HSA-162582,R-HSA-382551,R-HSA-5653656",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2006,0.8
,1,P11215,0,Growth abnormality (01507),disease,1,15,3684,1,,ENSG00000169896,protein-coding,0.41,integrin subunit alpha M,7.2128E-11,C0028754,Obesity,ITGAM,9,0,2018,0,"Hemostasis,Extracellular matrix organization,Immune System",0.91,"R-HSA-109582,R-HSA-1474244,R-HSA-168256",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.8
,1,"Q59FD4,P78542,B3KXY9,A0A994J753,P19367,A8K7J7",0,Growth abnormality (01507),disease,0.888888888888889,32,3098,0,,ENSG00000156515,protein-coding,0.44,hexokinase 1,1,C0028754,Obesity,HK1,44,0,,0,"Metabolism,Disease,Metabolism of proteins",0.87,"R-HSA-1430728,R-HSA-1643685,R-HSA-392499",345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.8
,0,P06276,0,Growth abnormality (01507),disease,0.916666666666667,45,590,4,,ENSG00000114200,protein-coding,0.42,butyrylcholinesterase,6.2149E-16,C0028754,Obesity,BCHE,117,2,2016,2,"Neuronal System,Metabolism,Metabolism of proteins,Drug ADME",0.91,"R-HSA-112316,R-HSA-1430728,R-HSA-392499,R-HSA-9748784",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2008,0.75
,0,"A0A384NL29,Q9UG59,Q96AM7,G5E9P6,P04179",0,Growth abnormality (01507),disease,0.833333333333333,192,6648,3,,ENSG00000291237,protein-coding,0.35,superoxide dismutase 2,0.032187,C0028754,Obesity,SOD2,5,0,2019,0,"Disease,Immune System,Organelle biogenesis and maintenance,Gene expression (Transcription),Cellular responses to stimuli",1,"R-HSA-1643685,R-HSA-168256,R-HSA-1852241,R-HSA-74160,R-HSA-8953897",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2005,0.75
,0,"B9A6J6,Q8NC59,Q6PJJ8,Q86TI0",0,Growth abnormality (01507),disease,0.875,2,23216,3,,ENSG00000065882,protein-coding,0.7,TBC1 domain family member 1,3.7433E-20,C0028754,Obesity,TBC1D1,4,0,2008,0,Vesicle-mediated transport,0.65,R-HSA-5653656,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2006,0.75
,0,"Q6FH11,P09601",0,Growth abnormality (01507),disease,1,83,3162,3,,ENSG00000100292,protein-coding,0.34,heme oxygenase 1,0.00000033466,C0028754,Obesity,HMOX1,5,0,2009,0,"Metabolism,Disease,Immune System,Transport of small molecules,Cellular responses to stimuli,Protein localization",0.96,"R-HSA-1430728,R-HSA-1643685,R-HSA-168256,R-HSA-382551,R-HSA-8953897,R-HSA-9609507",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2008,0.75
,0,"E9PCP0,F1T0G5,P16520",0,Growth abnormality (01507),disease,0.882352941176471,22,2784,2,,ENSG00000111664,protein-coding,0.52,G protein subunit beta 3,0.0000000037747,C0028754,Obesity,GNB3,4,0,2005,0,"Hemostasis,Neuronal System,Metabolism,Signal Transduction,Disease,Transport of small molecules,Metabolism of proteins,Sensory Perception",0.87,"R-HSA-109582,R-HSA-112316,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-382551,R-HSA-392499,R-HSA-9709957",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2005,0.75
,0,"B3KY43,P31323",0,Growth abnormality (01507),disease,1,3,5577,1,,ENSG00000005249,protein-coding,0.48,protein kinase cAMP-dependent type II regulatory subunit beta,0.53961,C0028754,Obesity,PRKAR2B,6,0,2010,0,"Hemostasis,Neuronal System,Metabolism,Signal Transduction,Cell Cycle,Disease,Organelle biogenesis and maintenance,Transport of small molecules",0.91,"R-HSA-109582,R-HSA-112316,R-HSA-1430728,R-HSA-162582,R-HSA-1640170,R-HSA-1643685,R-HSA-1852241,R-HSA-382551",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.75
,0,P01130,0,Growth abnormality (01507),disease,0.86,39,3949,1,,ENSG00000130164,protein-coding,0.41,low density lipoprotein receptor,1.1561E-30,C0028754,Obesity,LDLR,1920,0,2015,0,"Metabolism,Transport of small molecules,Vesicle-mediated transport,Sensory Perception",0.91,"R-HSA-1430728,R-HSA-382551,R-HSA-5653656,R-HSA-9709957",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2015,0.75
,0,"A0A0S2Z349,A0A0S2Z3C7,Q6P2H9,A0A8Q3SI60,P25942",0,Growth abnormality (01507),disease,1,36,958,1,,ENSG00000101017,protein-coding,0.39,CD40 molecule,0.030332,C0028754,Obesity,CD40,34,0,2018,0,Immune System,0.96,R-HSA-168256,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.75
,0,"V9HWB4,P11021",0,Growth abnormality (01507),disease,1,12,3309,1,,ENSG00000044574,protein-coding,0.43,heat shock protein family A (Hsp70) member 5,0.97758,C0028754,Obesity,HSPA5,0,0,2016,0,"Hemostasis,Immune System,Cellular responses to stimuli",0.96,"R-HSA-109582,R-HSA-168256,R-HSA-8953897",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.75
,0,,0,Growth abnormality (01507),disease,1,9,407040,1,,ENSG00000284357,ncRNA,0.42,microRNA 34a,,C0028754,Obesity,MIR34A,0,0,2013,0,,0.91,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.75
,0,Q8TDQ7,0,Growth abnormality (01507),disease,0.903225806451613,2,132789,1,,ENSG00000163281,protein-coding,0.72,glucosamine-6-phosphate deaminase 2,0.00015196,C0028754,Obesity,GNPDA2,0,0,2009,0,Metabolism,0.44,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.75
,0,P25774,0,Growth abnormality (01507),disease,1,4,1520,1,,ENSG00000163131,protein-coding,0.47,cathepsin S,0.19296,C0028754,Obesity,CTSS,6,0,2011,0,"Extracellular matrix organization,Immune System",0.91,"R-HSA-1474244,R-HSA-168256",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.75
,0,P23141,0,Growth abnormality (01507),disease,0.9,14,1066,1,,ENSG00000198848,protein-coding,0.57,carboxylesterase 1,1.284E-17,C0028754,Obesity,CES1,2,0,2010,0,"Metabolism,Metabolism of proteins,Muscle contraction,Drug ADME",0.78,"R-HSA-1430728,R-HSA-392499,R-HSA-397014,R-HSA-9748784",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.75
,0,P56704,0,Growth abnormality (01507),disease,0.956521739130435,2,89780,1,,ENSG00000154342,protein-coding,0.31,Wnt family member 3A,0.0079745,C0028754,Obesity,WNT3A,4,0,2017,0,"Developmental Biology,Signal Transduction,Disease",0.96,"R-HSA-1266738,R-HSA-162582,R-HSA-1643685",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2017,0.75
,0,"E3UN46,P01344",0,Growth abnormality (01507),disease,0.935897435897436,44,3481,1,,ENSG00000167244,protein-coding,0.34,insulin like growth factor 2,0.9599,C0028754,Obesity,IGF2,30,0,2001,0,"Hemostasis,Signal Transduction,Metabolism of proteins",0.96,"R-HSA-109582,R-HSA-162582,R-HSA-392499",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2001,0.75
,0,P34810,0,Growth abnormality (01507),disease,0.923076923076923,10,968,1,,ENSG00000129226,protein-coding,0.41,CD68 molecule,0.0000012699,C0028754,Obesity,CD68,2,0,2018,0,Immune System,0.91,R-HSA-168256,345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.75
,1,Q16619,0,Growth abnormality (01507),disease,1,11,1489,1,,ENSG00000150281,protein-coding,0.56,cardiotrophin 1,0.000001662,C0028754,Obesity,CTF1,59,0,2011,0,Immune System,0.74,R-HSA-168256,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.75
,0,P08588,0,Growth abnormality (01507),disease,0.842105263157895,25,153,1,,ENSG00000043591,protein-coding,0.49,adrenoceptor beta 1,0.1116,C0028754,Obesity,ADRB1,3,0,2002,0,Signal Transduction,0.91,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2002,0.75
,1,"P35638,Q53YD1",0,Growth abnormality (01507),disease,0.777777777777778,19,1649,1,,ENSG00000175197,protein-coding,0.43,DNA damage inducible transcript 3,0.00014788,C0028754,Obesity,DDIT3,20,0,2016,0,"Gene expression (Transcription),Cellular responses to stimuli",0.91,"R-HSA-74160,R-HSA-8953897",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.75
,0,P52789,0,Growth abnormality (01507),disease,0.875,5,3099,1,,ENSG00000159399,protein-coding,0.49,hexokinase 2,0.015191,C0028754,Obesity,HK2,0,0,2011,0,Metabolism,0.87,R-HSA-1430728,345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.75
,0,"O75469,F1D8P9",0,Growth abnormality (01507),disease,0.9,16,8856,1,,ENSG00000144852,protein-coding,0.48,nuclear receptor subfamily 1 group I member 2,1.1818E-13,C0028754,Obesity,NR1I2,4,0,2010,0,"Metabolism of proteins,Gene expression (Transcription)",0.91,"R-HSA-392499,R-HSA-74160",345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.75
,2,"A0A0A0MTG5,A8K673,Q5FBX5,P13232",0,Growth abnormality (01507),disease,1,11,3574,1,,ENSG00000104432,protein-coding,0.42,interleukin 7,0.48838,C0028754,Obesity,IL7,2,0,2010,0,Immune System,0.96,R-HSA-168256,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.75
,0,Q15761,0,Growth abnormality (01507),disease,0.75,4,4889,1,,ENSG00000164129,protein-coding,0.65,neuropeptide Y receptor Y5,0.00000095002,C0028754,Obesity,NPY5R,2,0,2000,0,Signal Transduction,0.61,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2000,0.75
,0,"B4DHQ0,E9PIE4,Q9Y6C9",0,Growth abnormality (01507),disease,0.9,1,23788,1,,ENSG00000109919,protein-coding,0.67,mitochondrial carrier 2,0.0040824,C0028754,Obesity,MTCH2,8,0,2009,0,,0.65,,345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.75
,2,"A8K257,P29466,A8K249",0,Growth abnormality (01507),disease,0.5,13,834,1,,ENSG00000137752,protein-coding,0.43,caspase 1,0.017506,C0028754,Obesity,CASP1,0,0,2012,0,"Disease,Immune System,Programmed Cell Death,Gene expression (Transcription)",0.91,"R-HSA-1643685,R-HSA-168256,R-HSA-5357801,R-HSA-74160",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2012,0.75
,0,P49715,0,Growth abnormality (01507),disease,0.956521739130435,17,1050,1,,ENSG00000245848,protein-coding,0.45,CCAAT enhancer binding protein alpha,0.26045,C0028754,Obesity,CEBPA,375,0,2017,0,Developmental Biology,0.91,R-HSA-1266738,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2017,0.75
,0,"P21673,A0A384NQ10",0,Growth abnormality (01507),disease,0.829787234042553,13,6303,1,,ENSG00000130066,protein-coding,0.5,spermidine/spermine N1-acetyltransferase 1,,C0028754,Obesity,SAT1,0,0,2011,0,Metabolism,0.87,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.75
,1,"A0A590UJL0,Q0W975,A6PYA4,P08842",0,Growth abnormality (01507),disease,0.875,13,412,1,,ENSG00000101846,protein-coding,0.45,steroid sulfatase,,C0028754,Obesity,STS,11,0,2014,0,"Metabolism,Metabolism of proteins",0.91,"R-HSA-1430728,R-HSA-392499",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2014,0.75
,0,Q96SI1,0,Growth abnormality (01507),disease,0.909090909090909,1,79047,1,,ENSG00000153885,protein-coding,0.67,potassium channel tetramerization domain containing 15,0.29883,C0028754,Obesity,KCTD15,1,0,2009,0,Gene expression (Transcription),0.61,R-HSA-74160,345,Enzyme modulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.75
,0,"O14520,Q6P5T0,Q5T5M0,B7Z4U2",0,Growth abnormality (01507),disease,0.954545454545455,2,364,1,,ENSG00000165269,protein-coding,0.64,aquaporin 7,0.00000021894,C0028754,Obesity,AQP7,2,1,2006,1,Transport of small molecules,0.61,R-HSA-382551,345,Ion channel,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2006,0.75
,0,Q01959,0,Growth abnormality (01507),disease,0.636363636363636,43,6531,0,,ENSG00000142319,protein-coding,0.43,solute carrier family 6 member 3,0.99999,C0028754,Obesity,SLC6A3,103,0,,0,"Neuronal System,Disease,Transport of small molecules",0.96,"R-HSA-112316,R-HSA-1643685,R-HSA-382551",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.75
,0,"Q59GX2,P11166",0,Growth abnormality (01507),disease,0.888888888888889,61,6513,0,,ENSG00000117394,protein-coding,0.38,solute carrier family 2 member 1,1,C0028754,Obesity,SLC2A1,414,0,,0,"Metabolism,Disease,Transport of small molecules",0.91,"R-HSA-1430728,R-HSA-1643685,R-HSA-382551",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.75
,0,"A0A0S2Z3A9,Q96RK4",0,Growth abnormality (01507),disease,1,9,585,0,,ENSG00000140463,protein-coding,0.56,Bardet-Biedl syndrome 4,6.6389E-12,C0028754,Obesity,BBS4,221,0,,0,Organelle biogenesis and maintenance,0.87,R-HSA-1852241,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.75
,0,"P08709,F5H8B0,B4DPM2",0,Growth abnormality (01507),disease,0.833333333333333,26,2155,0,,ENSG00000057593,protein-coding,0.44,coagulation factor VII,,C0028754,Obesity,F7,132,0,,0,"Hemostasis,Metabolism of proteins,Circadian Clock",0.91,"R-HSA-109582,R-HSA-392499,R-HSA-400253",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.75
,0,"Q8N3J6,G3XHN4",1,Growth abnormality (01507),disease,0.875,6,253559,0,,ENSG00000175161,protein-coding,0.57,cell adhesion molecule 2,0.96757,C0028754,Obesity,CADM2,140,0,,0,Cell-Cell communication,0.87,R-HSA-1500931,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.75
,0,Q5VV42,1,Growth abnormality (01507),disease,0.9375,9,54901,0,,ENSG00000145996,protein-coding,0.59,CDK5 regulatory subunit associated protein 1 like 1,0.4808,C0028754,Obesity,CDKAL1,64,0,,0,Metabolism of RNA,0.7,R-HSA-8953854,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.75
,1,P13686,0,Growth abnormality (01507),disease,1,5,54,1,,ENSG00000102575,protein-coding,0.45,"acid phosphatase 5, tartrate resistant",0.000000085281,C0028754,Obesity,ACP5,128,0,2011,0,Metabolism,0.91,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.7
,0,"A8K9T3,P33121,B4E0R0,E7EPM6",0,Growth abnormality (01507),disease,0.9,5,2180,1,,ENSG00000151726,protein-coding,0.52,acyl-CoA synthetase long chain family member 1,0.045987,C0028754,Obesity,ACSL1,13,0,2011,0,Metabolism,0.87,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.7
,0,"A0A7P0T9P7,A0A7P0T897,Q5VVF5,P98155",0,Growth abnormality (01507),disease,0.666666666666667,14,7436,1,,ENSG00000147852,protein-coding,0.53,very low density lipoprotein receptor,5.7808E-18,C0028754,Obesity,VLDLR,113,0,2010,0,"Developmental Biology,Transport of small molecules",0.83,"R-HSA-1266738,R-HSA-382551",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.7
,0,"A0A140VK76,B3KTT6,Q16836",0,Growth abnormality (01507),disease,0.75,8,3033,1,,ENSG00000138796,protein-coding,0.52,hydroxyacyl-CoA dehydrogenase,0.0050409,C0028754,Obesity,HADH,87,0,2011,0,"Metabolism,Metabolism of proteins",0.83,"R-HSA-1430728,R-HSA-392499",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.7
,0,P25929,0,Growth abnormality (01507),disease,1,15,4886,1,,ENSG00000164128,protein-coding,0.59,neuropeptide Y receptor Y1,0.50616,C0028754,Obesity,NPY1R,3,0,2010,0,Signal Transduction,0.74,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.7
,0,"A0A1W2PQU4,S4R453,A0A1W2PR56,A0A1W2PPY5,A0A1W2PQK5,Q59FH2,Q5SVJ7,A0A1W2PRN5,A0A1W2PP94,D5MRH1,A0A087WZL8,A0A1W2PR62,B7ZMF5,Q12791",1,Growth abnormality (01507),disease,1,24,3778,1,,ENSG00000156113,protein-coding,0.49,potassium calcium-activated channel subfamily M alpha 1,1,C0028754,Obesity,KCNMA1,361,1,2016,1,"Hemostasis,Neuronal System,Sensory Perception",0.91,"R-HSA-109582,R-HSA-112316,R-HSA-9709957",345,Ion channel,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.7
,0,P09067,1,Growth abnormality (01507),disease,1,1,3215,1,,ENSG00000120075,protein-coding,0.61,homeobox B5,0.036648,C0028754,Obesity,HOXB5,2,0,2012,0,,0.65,,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2012,0.7
,0,Q02577,0,Growth abnormality (01507),disease,0.9,16,4808,1,,ENSG00000177551,protein-coding,0.52,nescient helix-loop-helix 2,0.0018952,C0028754,Obesity,NHLH2,4,0,2010,0,,0.91,,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.7
,0,O15118,1,Growth abnormality (01507),disease,1,34,4864,1,,ENSG00000141458,protein-coding,0.53,NPC intracellular cholesterol transporter 1,5.6981E-11,C0028754,Obesity,NPC1,714,0,2009,0,Transport of small molecules,0.91,R-HSA-382551,345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.7
,0,P11226,0,Growth abnormality (01507),disease,0.857142857142857,84,4153,0,,ENSG00000165471,protein-coding,0.39,mannose binding lectin 2,0.027157,C0028754,Obesity,MBL2,77,0,,0,"Disease,Immune System",0.91,"R-HSA-1643685,R-HSA-168256",345,Receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,O15357,0,Growth abnormality (01507),disease,1,6,3636,0,,ENSG00000165458,protein-coding,0.56,inositol polyphosphate phosphatase like 1,8.0654E-19,C0028754,Obesity,INPPL1,32,0,,0,"Metabolism,Immune System",0.83,"R-HSA-1430728,R-HSA-168256",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,"P55055,F1D8P7",0,Growth abnormality (01507),disease,0.75,5,7376,0,,ENSG00000131408,protein-coding,0.49,nuclear receptor subfamily 1 group H member 2,0.00000017055,C0028754,Obesity,NR1H2,1,0,,0,"Metabolism,Signal Transduction,Transport of small molecules,Metabolism of proteins,Gene expression (Transcription)",0.87,"R-HSA-1430728,R-HSA-162582,R-HSA-382551,R-HSA-392499,R-HSA-74160",345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,P08949,0,Growth abnormality (01507),disease,1,2,4828,0,,ENSG00000197696,protein-coding,0.65,neuromedin B,0.000032655,C0028754,Obesity,NMB,1,0,,0,Signal Transduction,0.65,R-HSA-162582,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,P11802,0,Growth abnormality (01507),disease,1,34,1019,0,,ENSG00000135446,protein-coding,0.38,cyclin dependent kinase 4,0.5637,C0028754,Obesity,CDK4,339,0,,0,"Developmental Biology,Reproduction,Signal Transduction,Cell Cycle,Disease,Chromatin organization,Gene expression (Transcription),Cellular responses to stimuli",0.91,"R-HSA-1266738,R-HSA-1474165,R-HSA-162582,R-HSA-1640170,R-HSA-1643685,R-HSA-4839726,R-HSA-74160,R-HSA-8953897",345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,"Q59EE8,Q9Y6Q9",0,Growth abnormality (01507),disease,0.666666666666667,12,8202,0,,ENSG00000124151,protein-coding,0.53,nuclear receptor coactivator 3,1,C0028754,Obesity,NCOA3,3,0,,0,"Developmental Biology,Metabolism,Signal Transduction",0.74,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582",345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,Q6VVX0,0,Growth abnormality (01507),disease,1,17,120227,0,,ENSG00000186104,protein-coding,0.54,cytochrome P450 family 2 subfamily R member 1,2.4652E-12,C0028754,Obesity,CYP2R1,22,0,,0,"Metabolism,Disease",0.87,"R-HSA-1430728,R-HSA-1643685",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,O75056,0,Growth abnormality (01507),disease,1,2,9672,0,,ENSG00000162512,protein-coding,0.64,syndecan 3,0.26804,C0028754,Obesity,SDC3,4,0,,0,"Hemostasis,Metabolism,Extracellular matrix organization,Disease,Sensory Perception",0.61,"R-HSA-109582,R-HSA-1430728,R-HSA-1474244,R-HSA-1643685,R-HSA-9709957",345,Extracellular structure,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,O00744,0,Growth abnormality (01507),disease,0.9,9,7480,0,,ENSG00000169884,protein-coding,0.54,Wnt family member 10B,0.000000081161,C0028754,Obesity,WNT10B,27,0,,0,"Developmental Biology,Signal Transduction",0.83,"R-HSA-1266738,R-HSA-162582",345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,"Q59HC6,F8WE91,Q9Y6K1,A0A0C4DG02",1,Growth abnormality (01507),disease,1,56,1788,0,,ENSG00000119772,protein-coding,0.4,DNA methyltransferase 3 alpha,2.8201E-146,C0028754,Obesity,DNMT3A,142,0,,0,"Disease,Metabolism of proteins,Chromatin organization,Gene expression (Transcription)",0.96,"R-HSA-1643685,R-HSA-392499,R-HSA-4839726,R-HSA-74160",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,"Q9UN76,B2R8J1",0,Growth abnormality (01507),disease,0.8,4,11254,0,,ENSG00000268104,protein-coding,0.59,solute carrier family 6 member 14,,C0028754,Obesity,SLC6A14,1,0,,0,"Disease,Transport of small molecules",0.7,"R-HSA-1643685,R-HSA-382551",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,"A8K5I0,P0DMV9,P0DMV8",0,Growth abnormality (01507),disease,1,26,3304,0,,ENSG00000204388,protein-coding,0.48,heat shock protein family A (Hsp70) member 1B,0.0074976,C0028754,Obesity,HSPA1B,3,0,,0,"Disease,Immune System,Metabolism of RNA,Cellular responses to stimuli",0.91,"R-HSA-1643685,R-HSA-168256,R-HSA-8953854,R-HSA-8953897",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,P05090,0,Growth abnormality (01507),disease,1,11,347,0,,ENSG00000189058,protein-coding,0.51,apolipoprotein D,0.00000002698,C0028754,Obesity,APOD,1,0,,0,"Signal Transduction,Transport of small molecules",0.78,"R-HSA-162582,R-HSA-382551",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,P32238,0,Growth abnormality (01507),disease,1,10,886,0,,ENSG00000163394,protein-coding,0.57,cholecystokinin A receptor,0.0000047524,C0028754,Obesity,CCKAR,2,0,,0,Signal Transduction,0.83,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,"Q86WB6,A0A0B4J202,P48645,E9PDJ7,A0A250SH36",0,Growth abnormality (01507),disease,1,1,10874,0,,ENSG00000109255,protein-coding,0.58,neuromedin U,0.1017,C0028754,Obesity,NMU,2,0,,0,Signal Transduction,0.87,R-HSA-162582,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,"G3CIS4,B3TIK8,K9J956,P34998,B3SXS2",0,Growth abnormality (01507),disease,0.666666666666667,24,1394,0,,ENSG00000120088,protein-coding,0.51,corticotropin releasing hormone receptor 1,0.0041282,C0028754,Obesity,CRHR1,13,0,,0,Signal Transduction,0.96,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,P49238,0,Growth abnormality (01507),disease,0.833333333333333,17,1524,0,,ENSG00000168329,protein-coding,0.44,C-X3-C motif chemokine receptor 1,0.53262,C0028754,Obesity,CX3CR1,4,0,,0,"Signal Transduction,Disease",0.91,"R-HSA-162582,R-HSA-1643685",345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.7
,0,"A0A140VK05,B4DN86,Q92667",0,Growth abnormality (01507),disease,1,3,8165,1,,ENSG00000121057,protein-coding,0.64,A-kinase anchoring protein 1,0.66314,C0028754,Obesity,AKAP1,4,0,2010,0,"Hemostasis,Transport of small molecules",0.7,"R-HSA-109582,R-HSA-382551",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.65
,0,P21583,0,Growth abnormality (01507),disease,0.857142857142857,26,4254,1,,ENSG00000049130,protein-coding,0.37,KIT ligand,0.90363,C0028754,Obesity,KITLG,15,0,2013,0,"Developmental Biology,Signal Transduction,Disease",0.91,"R-HSA-1266738,R-HSA-162582,R-HSA-1643685",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.65
,0,Q6VY07,1,Growth abnormality (01507),disease,1,18,55690,1,,ENSG00000175115,protein-coding,0.57,phosphofurin acidic cluster sorting protein 1,1,C0028754,Obesity,PACS1,49,0,2013,0,Disease,0.83,R-HSA-1643685,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.65
,0,"Q99777,O95398",0,Growth abnormality (01507),disease,1,8,10411,1,,ENSG00000079337,protein-coding,0.55,Rap guanine nucleotide exchange factor 3,2.1102E-28,C0028754,Obesity,RAPGEF3,1,0,2018,0,"Hemostasis,Metabolism,Signal Transduction,Immune System",0.87,"R-HSA-109582,R-HSA-1430728,R-HSA-162582,R-HSA-168256",345,Enzyme modulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.65
,0,P09874,0,Growth abnormality (01507),disease,0.875,55,142,1,,ENSG00000143799,protein-coding,0.37,poly(ADP-ribose) polymerase 1,0.99939,C0028754,Obesity,PARP1,5,0,2010,0,"Signal Transduction,Disease,Metabolism of proteins,DNA Repair,Gene expression (Transcription)",0.96,"R-HSA-162582,R-HSA-1643685,R-HSA-392499,R-HSA-73894,R-HSA-74160",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.65
,0,O15245,0,Growth abnormality (01507),disease,1,4,6580,1,,ENSG00000175003,protein-coding,0.43,solute carrier family 22 member 1,1.7143E-15,C0028754,Obesity,SLC22A1,9,1,2011,1,"Neuronal System,Transport of small molecules,Drug ADME",0.91,"R-HSA-112316,R-HSA-382551,R-HSA-9748784",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.65
,0,Q8NER1,0,Growth abnormality (01507),disease,1,17,7442,1,,ENSG00000196689,protein-coding,0.47,transient receptor potential cation channel subfamily V member 1,5.9539E-30,C0028754,Obesity,TRPV1,1,0,2007,0,Transport of small molecules,1,R-HSA-382551,345,Ion channel,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2007,0.65
,0,O75390,0,Growth abnormality (01507),disease,1,9,1431,1,,ENSG00000062485,protein-coding,0.56,citrate synthase,,C0028754,Obesity,CS,4,0,2011,0,"Metabolism,Metabolism of proteins,Protein localization",0.78,"R-HSA-1430728,R-HSA-392499,R-HSA-9609507",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.65
,0,O00763,0,Growth abnormality (01507),disease,0.9,5,32,1,,ENSG00000076555,protein-coding,0.61,acetyl-CoA carboxylase beta,2.4266E-49,C0028754,Obesity,ACACB,12,0,2011,0,Metabolism,0.74,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.65
,0,O15240,0,Growth abnormality (01507),disease,1,7,7425,1,,ENSG00000128564,protein-coding,0.57,VGF nerve growth factor inducible,0.0087032,C0028754,Obesity,VGF,0,0,2002,0,"Signal Transduction,Metabolism of proteins",0.74,"R-HSA-162582,R-HSA-392499",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2002,0.65
,0,,0,Growth abnormality (01507),disease,1,9,406920,1,,ENSG00000283871,ncRNA,0.55,microRNA 130b,,C0028754,Obesity,MIR130B,0,0,2017,0,,0.83,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2017,0.65
,0,"Q8N2Y6,Q15911",0,Growth abnormality (01507),disease,0.666666666666667,29,463,1,,ENSG00000140836,protein-coding,0.48,zinc finger homeobox 3,1,C0028754,Obesity,ZFHX3,86,0,2018,0,Gene expression (Transcription),0.96,R-HSA-74160,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.65
,0,"Q96IY4,A0A087WSY5",0,Growth abnormality (01507),disease,1,3,1361,1,,ENSG00000080618,protein-coding,0.5,carboxypeptidase B2,3.0686E-10,C0028754,Obesity,CPB2,0,0,2006,0,"Immune System,Metabolism of proteins",0.87,"R-HSA-168256,R-HSA-392499",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2006,0.65
,0,"Q53TK1,Q16678",0,Growth abnormality (01507),disease,1,40,1545,1,,ENSG00000138061,protein-coding,0.43,cytochrome P450 family 1 subfamily B member 1,0.0000014942,C0028754,Obesity,CYP1B1,184,0,2016,0,"Metabolism,Disease",0.91,"R-HSA-1430728,R-HSA-1643685",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.65
,0,"P15559,B4DLR8",0,Growth abnormality (01507),disease,1,44,1728,1,,ENSG00000181019,protein-coding,0.44,NAD(P)H quinone dehydrogenase 1,0.000000023078,C0028754,Obesity,NQO1,2,0,2007,0,"Metabolism,Cellular responses to stimuli",0.91,"R-HSA-1430728,R-HSA-8953897",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2007,0.65
,0,"P99999,G4XXL9",0,Growth abnormality (01507),disease,1,23,54205,1,,ENSG00000172115,protein-coding,0.42,"cytochrome c, somatic",0.97706,C0028754,Obesity,CYCS,23,0,2005,0,"Metabolism,Organelle biogenesis and maintenance,Programmed Cell Death,Gene expression (Transcription),Cellular responses to stimuli",0.91,"R-HSA-1430728,R-HSA-1852241,R-HSA-5357801,R-HSA-74160,R-HSA-8953897",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2005,0.65
,0,"V9HWA3,P07451",0,Growth abnormality (01507),disease,1,5,761,1,,ENSG00000164879,protein-coding,0.52,carbonic anhydrase 3,0.000012791,C0028754,Obesity,CA3,0,0,2011,0,Metabolism,0.96,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.65
,0,P22897,0,Growth abnormality (01507),disease,1,6,4360,1,,ENSG00000260314,protein-coding,0.46,mannose receptor C-type 1,,C0028754,Obesity,MRC1,3,0,2018,0,"Disease,Immune System",0.87,"R-HSA-1643685,R-HSA-168256",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.65
,0,"Q0ZFD6,P00156",1,Growth abnormality (01507),disease,1,30,4519,1,,,protein-coding,0.49,cytochrome b,,C0028754,Obesity,CYTB,371,0,2003,0,Metabolism,0.87,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2003,0.65
,0,"P53396,Q4LE36",0,Growth abnormality (01507),disease,1,4,47,1,,ENSG00000131473,protein-coding,0.51,ATP citrate lyase,1,C0028754,Obesity,ACLY,1,0,2011,0,"Metabolism,Immune System",0.91,"R-HSA-1430728,R-HSA-168256",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.65
,0,O15244,0,Growth abnormality (01507),disease,1,5,6582,1,,ENSG00000112499,protein-coding,0.43,solute carrier family 22 member 2,0.000000059102,C0028754,Obesity,SLC22A2,3,1,2016,1,"Neuronal System,Transport of small molecules,Drug ADME",0.91,"R-HSA-112316,R-HSA-382551,R-HSA-9748784",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.65
,0,"Q6FG41,P01100",0,Growth abnormality (01507),disease,0.9,31,2353,1,,ENSG00000170345,protein-coding,0.36,"Fos proto-oncogene, AP-1 transcription factor subunit",0.8667,C0028754,Obesity,FOS,1,0,2016,0,"Signal Transduction,Immune System,Gene expression (Transcription),Cellular responses to stimuli",0.91,"R-HSA-162582,R-HSA-168256,R-HSA-74160,R-HSA-8953897",345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.65
,0,"F1DAL4,Q14994",0,Growth abnormality (01507),disease,1,8,9970,1,,ENSG00000143257,protein-coding,0.57,nuclear receptor subfamily 1 group I member 3,0.0000000031924,C0028754,Obesity,NR1I3,1,0,2010,0,Gene expression (Transcription),0.83,R-HSA-74160,345,Nuclear receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2010,0.65
,0,P22303,0,Growth abnormality (01507),disease,1,26,43,1,,ENSG00000087085,protein-coding,0.42,acetylcholinesterase (Yt blood group),0.81104,C0028754,Obesity,ACHE,3,0,2018,0,"Neuronal System,Metabolism,Metabolism of proteins",0.96,"R-HSA-112316,R-HSA-1430728,R-HSA-392499",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.65
,0,P23378,1,Growth abnormality (01507),disease,1,10,2731,1,,ENSG00000178445,protein-coding,0.54,glycine decarboxylase,2.3842E-21,C0028754,Obesity,GLDC,704,0,2000,0,Metabolism,0.87,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2000,0.65
,0,Q6VAB6,1,Growth abnormality (01507),disease,1,8,283455,1,,ENSG00000171435,protein-coding,0.69,kinase suppressor of ras 2,1,C0028754,Obesity,KSR2,22,0,2013,0,"Signal Transduction,Disease",0.61,"R-HSA-162582,R-HSA-1643685",345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.65
,0,P35558,0,Growth abnormality (01507),disease,1,10,5105,1,,ENSG00000124253,protein-coding,0.53,phosphoenolpyruvate carboxykinase 1,6.2994E-13,C0028754,Obesity,PCK1,63,0,2011,0,"Developmental Biology,Metabolism,Signal Transduction,Gene expression (Transcription),Drug ADME",0.74,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-74160,R-HSA-9748784",345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.65
,0,P48163,0,Growth abnormality (01507),disease,1,5,4199,1,,ENSG00000065833,protein-coding,0.57,malic enzyme 1,0.0000000045364,C0028754,Obesity,ME1,2,0,2009,0,"Metabolism,Cellular responses to stimuli",0.91,"R-HSA-1430728,R-HSA-8953897",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.65
,0,P80365,0,Growth abnormality (01507),disease,0.857142857142857,11,3291,0,,ENSG00000176387,protein-coding,0.51,hydroxysteroid 11-beta dehydrogenase 2,0.00000033476,C0028754,Obesity,HSD11B2,26,0,,0,"Metabolism,Drug ADME",0.87,"R-HSA-1430728,R-HSA-9748784",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.65
,0,"B4DYR6,O00429",1,Growth abnormality (01507),disease,0.666666666666667,18,10059,0,,ENSG00000087470,protein-coding,0.46,dynamin 1 like,0.92169,C0028754,Obesity,DNM1L,36,0,,0,Programmed Cell Death,0.91,R-HSA-5357801,345,Enzyme modulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.65
,0,"P07101,P78428",0,Growth abnormality (01507),disease,1,32,7054,0,,ENSG00000180176,protein-coding,0.45,tyrosine hydroxylase,,C0028754,Obesity,TH,329,0,,0,Metabolism,0.91,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.65
,0,"Q9BX66,B4DTX5",0,Growth abnormality (01507),disease,1,4,10580,0,,ENSG00000095637,protein-coding,0.65,sorbin and SH3 domain containing 1,0.0000000012101,C0028754,Obesity,SORBS1,9,0,,0,Muscle contraction,0.7,R-HSA-397014,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.65
,0,P18089,0,Growth abnormality (01507),disease,0.833333333333333,13,151,0,,ENSG00000274286,protein-coding,0.52,adrenoceptor alpha 2B,0.00000082996,C0028754,Obesity,ADRA2B,7,0,,0,"Hemostasis,Signal Transduction",0.83,"R-HSA-109582,R-HSA-162582",345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.65
,0,P24592,0,Growth abnormality (01507),disease,1,6,3489,0,,ENSG00000167779,protein-coding,0.55,insulin like growth factor binding protein 6,7.9711E-10,C0028754,Obesity,IGFBP6,1,0,,0,Metabolism of proteins,0.83,R-HSA-392499,345,Enzyme modulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.65
,0,Q9H221,0,Growth abnormality (01507),disease,1,18,64241,0,,ENSG00000143921,protein-coding,0.54,ATP binding cassette subfamily G member 8,4.8917E-31,C0028754,Obesity,ABCG8,171,0,,0,"Signal Transduction,Disease,Transport of small molecules",0.61,"R-HSA-162582,R-HSA-1643685,R-HSA-382551",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.65
,0,P51587,1,Growth abnormality (01507),disease,1,99,675,0,,ENSG00000139618,protein-coding,0.36,BRCA2 DNA repair associated,5.7691E-44,C0028754,Obesity,BRCA2,8841,0,,0,"Reproduction,Cell Cycle,Disease,DNA Repair",0.96,"R-HSA-1474165,R-HSA-1640170,R-HSA-1643685,R-HSA-73894",345,Nucleic acid binding,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.65
,0,P15954,0,Growth abnormality (01507),disease,1,1,1350,1,,ENSG00000127184,protein-coding,0.77,cytochrome c oxidase subunit 7C,0.6564,C0028754,Obesity,COX7C,0,0,2011,0,"Metabolism,Gene expression (Transcription),Cellular responses to stimuli",0.48,"R-HSA-1430728,R-HSA-74160,R-HSA-8953897",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.6
,0,O75751,0,Growth abnormality (01507),disease,1,6,6581,1,,ENSG00000146477,protein-coding,0.44,solute carrier family 22 member 3,5.2221E-14,C0028754,Obesity,SLC22A3,33,0,2016,0,"Transport of small molecules,Drug ADME",0.91,"R-HSA-382551,R-HSA-9748784",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.6
,0,,0,Growth abnormality (01507),disease,1,6,406919,1,,ENSG00000208009,ncRNA,0.52,microRNA 130a,,C0028754,Obesity,MIR130A,0,0,2017,0,,0.87,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2017,0.6
,0,"P02792,A0A384MDR3",0,Growth abnormality (01507),disease,1,18,2512,1,,ENSG00000087086,protein-coding,0.53,ferritin light chain,0.0000020735,C0028754,Obesity,FTL,77,0,2011,0,"Immune System,Transport of small molecules,Vesicle-mediated transport",0.91,"R-HSA-168256,R-HSA-382551,R-HSA-5653656",345,Storage,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.6
,0,"B2R5T5,P10644",0,Growth abnormality (01507),disease,1,26,5573,1,,ENSG00000108946,protein-coding,0.43,protein kinase cAMP-dependent type I regulatory subunit alpha,1,C0028754,Obesity,PRKAR1A,346,0,2018,0,"Hemostasis,Neuronal System,Metabolism,Signal Transduction,Disease,Transport of small molecules",0.96,"R-HSA-109582,R-HSA-112316,R-HSA-1430728,R-HSA-162582,R-HSA-1643685,R-HSA-382551",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.6
,0,P98172,0,Growth abnormality (01507),disease,1,9,1947,1,,ENSG00000090776,protein-coding,0.52,ephrin B1,,C0028754,Obesity,EFNB1,32,0,2013,0,Developmental Biology,0.87,R-HSA-1266738,345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.6
,0,"Q6P1N1,Q9P0J1",0,Growth abnormality (01507),disease,0.5,4,54704,0,,ENSG00000164951,protein-coding,0.61,pyruvate dehydrogenase phosphatase catalytic subunit 1,0.93829,C0028754,Obesity,PDP1,10,0,,0,Metabolism,0.78,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.6
,0,Q96FI4,0,Growth abnormality (01507),disease,1,11,79661,2,,ENSG00000140398,protein-coding,0.61,nei like DNA glycosylase 1,0.000000094071,C0028754,Obesity,NEIL1,4,0,2011,0,"Disease,DNA Repair",0.83,"R-HSA-1643685,R-HSA-73894",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2006,0.55
,0,"B4DDM7,B4DU64,O75354,B4DHS2,B4E1D1",0,Growth abnormality (01507),disease,1,2,955,1,,ENSG00000197586,protein-coding,0.8,ectonucleoside triphosphate diphosphohydrolase 6,1.4217E-11,C0028754,Obesity,ENTPD6,8,0,2018,0,Metabolism,0.35,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.55
,0,,0,Growth abnormality (01507),disease,1,4,406960,1,,ENSG00000207695,ncRNA,0.54,microRNA 184,,C0028754,Obesity,MIR184,3,0,2013,0,,0.87,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.55
,0,Q9BY12,1,Growth abnormality (01507),disease,1,15,49855,1,,ENSG00000140386,protein-coding,0.55,S-phase cyclin A associated protein in the ER,1.9905E-11,C0028754,Obesity,SCAPER,54,0,2019,0,,0.96,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2019,0.55
,0,Q12882,0,Growth abnormality (01507),disease,1,52,1806,1,,ENSG00000188641,protein-coding,0.45,dihydropyrimidine dehydrogenase,5.5849E-30,C0028754,Obesity,DPYD,220,0,2011,0,Metabolism,0.91,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.55
,0,"P14902,A0A348GSI3",0,Growth abnormality (01507),disease,1,13,3620,1,,ENSG00000131203,protein-coding,0.47,"indoleamine 2,3-dioxygenase 1",0.000046979,C0028754,Obesity,IDO1,0,0,2016,0,Metabolism,0.91,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2016,0.55
,0,"Q7Z6C1,Q09472",0,Growth abnormality (01507),disease,1,56,2033,1,,ENSG00000100393,protein-coding,0.42,E1A binding protein p300,1,C0028754,Obesity,EP300,224,1,2015,1,"Developmental Biology,Metabolism,Signal Transduction,Cell Cycle,Disease,Immune System,Metabolism of proteins,Circadian Clock,Chromatin organization,Gene expression (Transcription),Cellular responses to stimuli",0.96,"R-HSA-1266738,R-HSA-1430728,R-HSA-162582,R-HSA-1640170,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-400253,R-HSA-4839726,R-HSA-74160,R-HSA-8953897",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2015,0.55
,0,Q96C11,0,Growth abnormality (01507),disease,1,2,55277,1,,ENSG00000172456,protein-coding,0.75,FGGY carbohydrate kinase domain containing,2.3937E-16,C0028754,Obesity,FGGY,8,0,2018,0,,0.52,,345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.55
,0,Q14929,0,Growth abnormality (01507),disease,1,1,169841,1,,ENSG00000175787,protein-coding,0.85,zinc finger protein 169,0.0002082,C0028754,Obesity,ZNF169,3,0,2018,0,Gene expression (Transcription),0.17,R-HSA-74160,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.55
,0,O60861,0,Growth abnormality (01507),disease,1,1,8522,1,,ENSG00000007237,protein-coding,0.63,growth arrest specific 7,0.023744,C0028754,Obesity,GAS7,16,0,2009,0,,0.7,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.55
,0,Q9NRR6,0,Growth abnormality (01507),disease,1,38,56623,1,,ENSG00000148384,protein-coding,0.52,inositol polyphosphate-5-phosphatase E,1.1742E-11,C0028754,Obesity,INPP5E,286,0,2009,0,"Metabolism,Organelle biogenesis and maintenance",0.74,"R-HSA-1430728,R-HSA-1852241",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2009,0.55
,0,O15156,0,Growth abnormality (01507),disease,1,1,51043,1,,ENSG00000160685,protein-coding,0.58,zinc finger and BTB domain containing 7B,0.98394,C0028754,Obesity,ZBTB7B,9,0,2018,0,,0.87,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.55
,0,P24723,1,Growth abnormality (01507),disease,1,6,5583,1,,ENSG00000027075,protein-coding,0.5,protein kinase C eta,0.99725,C0028754,Obesity,PRKCH,11,0,2013,0,"Hemostasis,Signal Transduction",0.87,"R-HSA-109582,R-HSA-162582",345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2013,0.55
,0,Q9UHB7,0,Growth abnormality (01507),disease,1,8,27125,1,,ENSG00000072364,protein-coding,0.55,ALF transcription elongation factor 4,1,C0028754,Obesity,AFF4,69,0,2015,0,Gene expression (Transcription),0.87,R-HSA-74160,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2015,0.55
,0,Q96K80,0,Growth abnormality (01507),disease,0,3,84872,1,,ENSG00000135482,protein-coding,0.85,zinc finger CCCH-type containing 10,0.049098,C0028754,Obesity,ZC3H10,1,0,2019,0,,0.22,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2019,0.55
,0,"B4DMF6,O75192,B2R8C6",0,Growth abnormality (01507),disease,1,4,8800,1,,ENSG00000166821,protein-coding,0.74,peroxisomal biogenesis factor 11 alpha,0.00011204,C0028754,Obesity,PEX11A,1,0,2019,0,Metabolism,0.48,R-HSA-1430728,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2019,0.55
,0,O60669,0,Growth abnormality (01507),disease,1,1,9194,1,,ENSG00000118596,protein-coding,0.63,solute carrier family 16 member 7,0.0000000022409,C0028754,Obesity,SLC16A7,5,0,2011,0,Transport of small molecules,0.74,R-HSA-382551,345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.55
,0,Q9UPR6,0,Growth abnormality (01507),disease,1,1,23217,1,,ENSG00000105278,protein-coding,0.85,zinc finger RNA binding protein 2,3.087E-44,C0028754,Obesity,ZFR2,2,0,2018,0,,0.17,,345,Nucleic acid binding,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.55
,0,"A8YXX4,P15104",0,Growth abnormality (01507),disease,1,17,2752,1,,ENSG00000135821,protein-coding,0.46,glutamate-ammonia ligase,0.9997,C0028754,Obesity,GLUL,115,0,2011,0,"Neuronal System,Metabolism",0.91,"R-HSA-112316,R-HSA-1430728",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.55
,0,"G4XH68,Q13304",0,Growth abnormality (01507),disease,1,7,2840,1,,ENSG00000144230,protein-coding,0.62,G protein-coupled receptor 17,0.013761,C0028754,Obesity,GPR17,3,0,2021,0,Signal Transduction,0.78,R-HSA-162582,345,G-protein coupled receptor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2021,0.55
,0,Q9UL25,0,Growth abnormality (01507),disease,1,1,23011,1,,ENSG00000080371,protein-coding,0.74,"RAB21, member RAS oncogene family",0.020636,C0028754,Obesity,RAB21,1,0,2018,0,"Metabolism of proteins,Vesicle-mediated transport",0.39,"R-HSA-392499,R-HSA-5653656",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.55
,0,"A0A8I5KYD6,A0A8I5KXS9,Q9NVM4",2,Growth abnormality (01507),disease,1,20,54496,0,,ENSG00000132600,protein-coding,0.56,protein arginine methyltransferase 7,1.6648E-16,C0028754,Obesity,PRMT7,38,0,,0,Chromatin organization,0.83,R-HSA-4839726,345,Epigenetic regulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.55
,0,Q7Z3K3,1,Growth abnormality (01507),disease,1,30,23126,0,,ENSG00000143442,protein-coding,0.55,pogo transposable element derived with ZNF domain,1,C0028754,Obesity,POGZ,144,0,,0,,0.83,,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.55
,0,"Q30201,B4DV50,F8W7W8",0,Growth abnormality (01507),disease,1,73,3077,0,,ENSG00000010704,protein-coding,0.42,homeostatic iron regulator,9.9398E-10,C0028754,Obesity,HFE,92,0,,0,Transport of small molecules,0.91,R-HSA-382551,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.55
,0,"P03886,U5Z754",0,Growth abnormality (01507),disease,0.5,64,4535,0,,,protein-coding,0.48,NADH dehydrogenase subunit 1,,C0028754,Obesity,ND1,181,0,,0,"Metabolism,Metabolism of proteins",0.87,"R-HSA-1430728,R-HSA-392499",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.55
,0,"A0A384NY14,Q7Z4W1",0,Growth abnormality (01507),disease,1,3,51181,1,,ENSG00000169738,protein-coding,0.7,dicarbonyl and L-xylulose reductase,3.5615E-10,C0028754,Obesity,DCXR,2,0,2011,0,"Metabolism,Disease",0.39,"R-HSA-1430728,R-HSA-1643685",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.5
,0,Q8J025,0,Growth abnormality (01507),disease,1,3,147495,1,,ENSG00000154856,protein-coding,0.66,APC down-regulated 1,0.59013,C0028754,Obesity,APCDD1,4,0,2017,0,,0.7,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2017,0.5
,0,"E5KS60,Q9P2R7,Q9Y4T0",0,Growth abnormality (01507),disease,1,7,8803,1,,ENSG00000136143,protein-coding,0.55,succinate-CoA ligase ADP-forming subunit beta,0.00011854,C0028754,Obesity,SUCLA2,103,0,2011,0,Metabolism,0.83,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.5
,0,"E5KPN0,O15527,E5KPN1,E5KPM9,E5KPM6,E5KPM8,E5KPM7,E5KPM5",0,Growth abnormality (01507),disease,1,57,4968,1,,ENSG00000114026,protein-coding,0.45,8-oxoguanine DNA glycosylase,7.2253E-12,C0028754,Obesity,OGG1,2,0,2018,0,"Disease,DNA Repair",0.91,"R-HSA-1643685,R-HSA-73894",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2018,0.5
,0,"B4DKT3,P42330,A0A0A0MSS8",0,Growth abnormality (01507),disease,1,16,8644,1,,ENSG00000196139,protein-coding,0.51,aldo-keto reductase family 1 member C3,8.7918E-11,C0028754,Obesity,AKR1C3,3,0,2011,0,"Metabolism,Signal Transduction,Sensory Perception",0.83,"R-HSA-1430728,R-HSA-162582,R-HSA-9709957",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.5
,0,"P00167,A0A384ME44",0,Growth abnormality (01507),disease,1,6,1528,1,,ENSG00000166347,protein-coding,0.58,cytochrome b5 type A,0.037924,C0028754,Obesity,CYB5A,4,0,2011,0,"Metabolism,Protein localization",0.78,"R-HSA-1430728,R-HSA-9609507",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.5
,0,Q06210,0,Growth abnormality (01507),disease,1,7,2673,1,,ENSG00000198380,protein-coding,0.57,glutamine--fructose-6-phosphate transaminase 1,0.022094,C0028754,Obesity,GFPT1,240,0,2011,0,"Disease,Metabolism of proteins,Cellular responses to stimuli",0.83,"R-HSA-1643685,R-HSA-392499,R-HSA-8953897",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.5
,0,"Q16875,B7Z8A0",0,Growth abnormality (01507),disease,1,11,5209,1,,ENSG00000170525,protein-coding,0.54,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",0.0051837,C0028754,Obesity,PFKFB3,5,0,2011,0,Metabolism,0.91,R-HSA-1430728,345,Kinase,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.5
,0,"Q86XK2,A0A804HK63",1,Growth abnormality (01507),disease,,9,80204,0,,ENSG00000138081,protein-coding,0.53,F-box protein 11,1,C0028754,Obesity,FBXO11,518,0,,0,"Immune System,Metabolism of proteins",0.91,"R-HSA-168256,R-HSA-392499",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.45
,0,A8MTZ0,1,Growth abnormality (01507),disease,,13,92482,0,,ENSG00000214413,protein-coding,0.57,BBSome interacting protein 1,0.073606,C0028754,Obesity,BBIP1,25,0,,0,Organelle biogenesis and maintenance,0.87,R-HSA-1852241,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.45
,0,,5,Growth abnormality (01507),disease,1,2,497258,0,,ENSG00000245573,ncRNA,0.61,BDNF antisense RNA,,C0028754,Obesity,BDNF-AS,46,0,,0,,0.83,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.45
,0,"Q8WXH0,Q6MZP0",1,Growth abnormality (01507),disease,,20,23224,0,,ENSG00000054654,protein-coding,0.53,spectrin repeat containing nuclear envelope protein 2,2.2033E-30,C0028754,Obesity,SYNE2,1218,0,,0,"Reproduction,Cell Cycle",0.83,"R-HSA-1474165,R-HSA-1640170",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.45
,0,"B3KPM6,O94830",1,Growth abnormality (01507),disease,1,6,23259,4,,ENSG00000085788,protein-coding,0.62,DDHD domain containing 2,0.0000012514,C0028754,Obesity,DDHD2,91,0,2014,0,Metabolism,0.78,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2012,0.4
,0,,3,Growth abnormality (01507),disease,1,3,100126793,3,,ENSG00000240288,ncRNA,0.85,ghrelin opposite strand/antisense RNA,,C0028754,Obesity,GHRLOS,4,0,2005,0,,0.22,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2001,0.4
,0,,0,Growth abnormality (01507),disease,1,52,125316803,2,,ENSG00000291307,protein-coding,0.65,POLG alternative reading frame,,C0028754,Obesity,POLGARF,0,0,2008,0,,0.61,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2003,0.4
,0,"P54098,E5KNU5",1,Growth abnormality (01507),disease,1,77,5428,2,,ENSG00000140521,protein-coding,0.44,"DNA polymerase gamma, catalytic subunit",2.0281E-26,C0028754,Obesity,POLG,960,0,2008,0,,0.96,,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2003,0.4
,0,Q96I99,0,Growth abnormality (01507),disease,1,6,8801,1,,ENSG00000172340,protein-coding,0.65,succinate-CoA ligase GDP-forming subunit beta,4.0462E-12,C0028754,Obesity,SUCLG2,21,0,2011,0,"Metabolism,Metabolism of proteins",0.57,"R-HSA-1430728,R-HSA-392499",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,"P22033,B2R6K1,A0A024RD82",0,Growth abnormality (01507),disease,1,14,4594,1,,ENSG00000146085,protein-coding,0.52,methylmalonyl-CoA mutase,4.6749E-22,C0028754,Obesity,MMUT,328,0,2011,0,"Metabolism,Disease",0.83,"R-HSA-1430728,R-HSA-1643685",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,"P11310,Q5HYG7,B4DJE7,Q5T4U5,B7Z9I1,A0A0S2Z366",0,Growth abnormality (01507),disease,1,8,34,1,,ENSG00000117054,protein-coding,0.58,acyl-CoA dehydrogenase medium chain,6.6928E-12,C0028754,Obesity,ACADM,328,0,2011,0,Metabolism,0.65,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,P22695,0,Growth abnormality (01507),disease,1,6,7385,1,,ENSG00000140740,protein-coding,0.65,ubiquinol-cytochrome c reductase core protein 2,5.8868E-15,C0028754,Obesity,UQCRC2,8,0,2011,0,"Metabolism,Metabolism of proteins",0.65,"R-HSA-1430728,R-HSA-392499",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,Q5SGD2,0,Growth abnormality (01507),disease,1,1,151742,1,,ENSG00000163590,protein-coding,0.59,"protein phosphatase, Mg2+/Mn2+ dependent 1L",0.46583,C0028754,Obesity,PPM1L,7,0,2008,0,Metabolism,0.7,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2008,0.4
,0,P30084,0,Growth abnormality (01507),disease,1,6,1892,1,,ENSG00000127884,protein-coding,0.62,"enoyl-CoA hydratase, short chain 1",0.00092335,C0028754,Obesity,ECHS1,54,0,2011,0,Metabolism,0.7,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,"Q16134,B4DEQ0",0,Growth abnormality (01507),disease,1,16,2110,1,,ENSG00000171503,protein-coding,0.59,electron transfer flavoprotein dehydrogenase,0.0000076175,C0028754,Obesity,ETFDH,293,0,2011,0,Metabolism,0.65,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,"Q02252,A0A024R6G4",0,Growth abnormality (01507),disease,1,6,4329,1,,ENSG00000119711,protein-coding,0.64,aldehyde dehydrogenase 6 family member A1,0.0000000043977,C0028754,Obesity,ALDH6A1,63,0,2011,0,Metabolism,0.65,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,"Q9NR63,E7ER08",0,Growth abnormality (01507),disease,1,7,56603,1,,ENSG00000003137,protein-coding,0.6,cytochrome P450 family 26 subfamily B member 1,0.99987,C0028754,Obesity,CYP26B1,12,0,2011,0,"Metabolism,Signal Transduction,Disease",0.74,"R-HSA-1430728,R-HSA-162582,R-HSA-1643685",345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,"Q5TC12,I3L448,A8MRA7",0,Growth abnormality (01507),disease,1,1,64756,1,,ENSG00000123472,protein-coding,0.82,ATP synthase mitochondrial F1 complex assembly factor 1,,C0028754,Obesity,ATPAF1,1,0,2011,0,,0.3,,345,Chaperone,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,Q9Y266,4,Growth abnormality (01507),disease,1,3,10726,1,,ENSG00000090273,protein-coding,0.71,"nuclear distribution C, dynein complex regulator",0.97098,C0028754,Obesity,NUDC,9,0,2008,0,"Signal Transduction,Cell Cycle",0.39,"R-HSA-162582,R-HSA-1640170",345,Cellular structure,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2008,0.4
,0,P26583,0,Growth abnormality (01507),disease,1,5,3148,1,,ENSG00000164104,protein-coding,0.57,high mobility group box 2,0.99963,C0028754,Obesity,HMGB2,0,0,2011,0,Programmed Cell Death,0.74,R-HSA-5357801,345,Nucleic acid binding,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,"O75891,Q53H87",0,Growth abnormality (01507),disease,1,5,10840,1,,ENSG00000144908,protein-coding,0.63,aldehyde dehydrogenase 1 family member L1,2.4788E-15,C0028754,Obesity,ALDH1L1,7,0,2011,0,Metabolism,0.83,R-HSA-1430728,345,Enzyme,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2011,0.4
,0,P83111,0,Growth abnormality (01507),disease,1,1,114294,1,,ENSG00000103642,protein-coding,0.65,lactamase beta,0.000000047901,C0028754,Obesity,LACTB,2,0,2008,0,,0.61,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,2008,0.4
,0,,1,Growth abnormality (01507),disease,,3,101927837,0,,ENSG00000270049,ncRNA,1,ATP6V0D1 divergent transcript,,C0028754,Obesity,ATP6V0D1-DT,3,0,,0,,0.09,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,P21817,1,Growth abnormality (01507),disease,,96,6261,0,,ENSG00000196218,protein-coding,0.44,ryanodine receptor 1,1.7594E-56,C0028754,Obesity,RYR1,1621,0,,0,"Transport of small molecules,Muscle contraction",0.91,"R-HSA-382551,R-HSA-397014",345,Ion channel,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"Q9HBD4,P51532,B3KNW7,A7E2E1",1,Growth abnormality (01507),disease,,40,6597,0,,ENSG00000127616,protein-coding,0.43,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",1,C0028754,Obesity,SMARCA4,1653,0,,0,"Developmental Biology,Signal Transduction,Immune System,Chromatin organization,Gene expression (Transcription)",0.91,"R-HSA-1266738,R-HSA-162582,R-HSA-168256,R-HSA-4839726,R-HSA-74160",345,Epigenetic regulator,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"Q86XV3,Q9Y2E4,A0A0U1RQW6",1,Growth abnormality (01507),disease,,7,22982,0,,ENSG00000151240,protein-coding,0.69,disco interacting protein 2 homolog C,1,C0028754,Obesity,DIP2C,11,0,,0,,0.52,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,Q8N766,1,Growth abnormality (01507),disease,,9,23065,0,,ENSG00000127463,protein-coding,0.61,ER membrane protein complex subunit 1,9.4991E-26,C0028754,Obesity,EMC1,47,0,,0,,0.74,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"O95239,Q59HG1",1,Growth abnormality (01507),disease,,18,24137,0,,ENSG00000090889,protein-coding,0.57,kinesin family member 4A,,C0028754,Obesity,KIF4A,10,0,,0,"Hemostasis,Developmental Biology,Immune System,Vesicle-mediated transport",0.83,"R-HSA-109582,R-HSA-1266738,R-HSA-168256,R-HSA-5653656",345,Cellular structure,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"Q9HCE3,B3KXW2",1,Growth abnormality (01507),disease,,4,55205,0,,ENSG00000074657,protein-coding,0.78,zinc finger protein 532,1,C0028754,Obesity,ZNF532,6,0,,0,,0.35,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,,0,Growth abnormality (01507),disease,,2,129933280,0,,,biological-region,0.94,ATAC-STARR-seq lymphoblastoid silent region 11244,,C0028754,Obesity,LOC129933280,0,0,,0,,0.13,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"A0A0D9SEM5,A0A1D5RMU6,H7BYC7,E7EQN4,E7ERL8,Q9ULB1,H0Y568,P58400,A0A0D9SEQ7",1,Growth abnormality (01507),disease,,27,9378,0,,ENSG00000179915,protein-coding,0.53,neurexin 1,1,C0028754,Obesity,NRXN1,719,0,,0,"Neuronal System,Extracellular matrix organization",0.91,"R-HSA-112316,R-HSA-1474244",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,,0,Growth abnormality (01507),disease,,2,126862765,0,,,biological-region,0.94,BRD4-independent group 4 enhancer GRCh37_chr18:56650842-56652041,,C0028754,Obesity,LOC126862765,0,0,,0,,0.13,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"G1UI33,P35580",1,Growth abnormality (01507),disease,,16,4628,0,,ENSG00000133026,protein-coding,0.6,myosin heavy chain 10,1,C0028754,Obesity,MYH10,8,0,,0,"Developmental Biology,Signal Transduction",0.91,"R-HSA-1266738,R-HSA-162582",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,P35498,1,Growth abnormality (01507),disease,,55,6323,0,,ENSG00000144285,protein-coding,0.43,sodium voltage-gated channel alpha subunit 1,1,C0028754,Obesity,SCN1A,1792,0,,0,"Developmental Biology,Muscle contraction",0.96,"R-HSA-1266738,R-HSA-397014",345,Ion channel,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,Q7L4I2,1,Growth abnormality (01507),disease,,6,65117,0,,ENSG00000111011,protein-coding,0.74,arginine and serine rich coiled-coil 2,1,C0028754,Obesity,RSRC2,5,0,,0,,0.39,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"Q06710,R9W7C9",1,Growth abnormality (01507),disease,,18,7849,0,,ENSG00000125618,protein-coding,0.43,paired box 8,0.99965,C0028754,Obesity,PAX8,112,0,,0,Developmental Biology,0.87,R-HSA-1266738,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,P35579,1,Growth abnormality (01507),disease,,43,4627,0,,ENSG00000100345,protein-coding,0.47,myosin heavy chain 9,1,C0028754,Obesity,MYH9,269,0,,0,"Developmental Biology,Signal Transduction,Disease,Immune System,Vesicle-mediated transport,Sensory Perception",0.83,"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-168256,R-HSA-5653656,R-HSA-9709957",345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,Q5T011,1,Growth abnormality (01507),disease,,18,23334,0,,ENSG00000198198,protein-coding,0.59,SZT2 subunit of KICSTOR complex,3.8854E-26,C0028754,Obesity,SZT2,390,0,,0,Cellular responses to stimuli,0.65,R-HSA-8953897,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"A0A994J6J2,P48058,Q1WWK6,A0A8D9PH77",1,Growth abnormality (01507),disease,,7,2893,0,,ENSG00000152578,protein-coding,0.59,glutamate ionotropic receptor AMPA type subunit 4,0.99929,C0028754,Obesity,GRIA4,35,0,,0,Neuronal System,0.83,R-HSA-112316,345,Ion channel,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,Q155Q3,1,Growth abnormality (01507),disease,,9,85458,0,,ENSG00000150764,protein-coding,0.65,DIX domain containing 1,5.8008E-12,C0028754,Obesity,DIXDC1,2,0,,0,,0.52,,345,Signaling,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"Q8IVL0,A0A2R8YFX5",0,Growth abnormality (01507),disease,,10,89795,0,,ENSG00000067798,protein-coding,0.64,neuron navigator 3,1,C0028754,Obesity,NAV3,19,0,,0,,0.78,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,Q9H598,0,Growth abnormality (01507),disease,,7,140679,0,,ENSG00000101438,protein-coding,0.59,solute carrier family 32 member 1,0.99954,C0028754,Obesity,SLC32A1,14,0,,0,"Neuronal System,Transport of small molecules",0.74,"R-HSA-112316,R-HSA-382551",345,Transporter,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"A0A0A0MSW5,Q96MU6",1,Growth abnormality (01507),disease,,4,197320,0,,ENSG00000170100,protein-coding,0.9,zinc finger protein 778,1.3206E-12,C0028754,Obesity,ZNF778,2,0,,0,Gene expression (Transcription),0.3,R-HSA-74160,345,Transcription factor,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,Q2VWP7,1,Growth abnormality (01507),disease,,2,283659,0,,ENSG00000166450,protein-coding,0.77,protogenin,0.0000003935,C0028754,Obesity,PRTG,6,0,,0,,0.44,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,"A0A090N7W1,Q12809,A0A090N8Q0,Q15BH2,A0A090N7X5",1,Growth abnormality (01507),disease,,36,3757,0,,ENSG00000055118,protein-coding,0.47,potassium voltage-gated channel subfamily H member 2,0.064733,C0028754,Obesity,KCNH2,1213,0,,0,"Neuronal System,Muscle contraction",0.91,"R-HSA-112316,R-HSA-397014",345,Ion channel,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,,0,Growth abnormality (01507),disease,,2,108167315,0,,,biological-region,0.94,POMC promoter region,,C0028754,Obesity,LOC108167315,0,0,,0,,0.13,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,,0,Growth abnormality (01507),disease,,4,114803475,0,,,biological-region,0.9,PPARG eExon liver enhancer,,C0028754,Obesity,LOC114803475,0,0,,0,,0.22,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
,0,,1,Growth abnormality (01507),disease,,4,100873952,0,,ENSG00000229372,ncRNA,0.87,SZT2 antisense RNA 1,,C0028754,Obesity,SZT2-AS1,35,0,,0,,0.22,,345,,disease of metabolism (0014667),"Nutritional and Metabolic Diseases,Pathological Conditions, Signs and Symptoms",Disease or Syndrome (T047),300,,0.4
